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The effect of a homologous series of pure dodecyl ether ethoxylate 
surfactants on the absorption of steroids through porcine skin has been determined. 
The effect of the same series of surfactants upon the fluidity of model lipid bilayers 
was investigated by a variety of physical techniques in an attempt to correlate lipid 
bilayer fluidity with skin penetration enhancement.
The introduction includes a review of the use of nonionic surfactants as 
enhancers of percutaneous absorption and of the proposed mechanisms of action of 
skin penetration enhancers. The experimental work is divided into four sections. In 
the first section the fluidisation of lipid bilayers was studied by differential scanning 
calorimetery (DSC). This work showed C 1 2 E3  to be the most potent fluidiser of 
lipid bilayers. This compound also reduced the lipid melting temperature in both 
extracted skin lipids and whole stratum comeum. In the second section using a 
variety of fluorescent membrane probes it was shown that molecules with low 
ethoxy content C1 2 E2 -C1 2 E4  fluidised the lipid bilayer core whilst the more 
hydrophilic molecules C1 2 E5 -C1 2 E7  fluidised the bilayer headgroup region. In the 
third section the more hydrophilic molecules were found to be the most potent 
fluidisers when studied by electron spin resonance spectroscopy. By use of this 
method lipid bilayer fluidisation by surfactants was also observed in whole stratum 
comeum. In the final section in-vitro skin permeation studies showed C 1 2 E3  to be 
the most potent penetration enhancer for both polar and nonpolar steroids. The 
more hydrophilic surfactants were relatively more potent enhancers for polar 
steroids.
The findings of these four experimental sections have been correlated and 
discussed in relation to mechanisms of permeation enhancement. The data suggests 
different modes of action for the enhancement of polar and nonpolar permeants and 
highlights the link between lipid bilayer fluidisation and penetration enhancement.
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1.1 Transdermal Drug Delivery
The skin has become recognised as a feasible and important route for the 
delivery of systemically acting drugs. There are many potential advantages of 
transdermal drug delivery over oral dosing, especially if the drug is administered 
from a transdermal drug delivery system (TDS) which controls the rate of delivery 
(1).
A number of TDS systems are already marketed for the delivery of 
nitroglycerin (Deponit^), oestradiol (Estraderm^), Scopolomine (Transderm^-Scop) 
and Clonidine (Catapres-TTS*^). These systems are in the form of small adhesive 
patches. The effective rate of drug delivery from these systems is however not 
controlled by the TDS but by the rate of percutaneous absorption of the drug. This 
highlights one of the main problems associated with the transdermal route. The 
skin has a low permeability for most drug compounds, therefore the transdermal 
route can at present only be used for very potent drugs that have the right 
physiochemical characteristics for absorption through the skin. This limits the 
range of drugs at present suitable for these systems. For controlled transdermal 
delivery of drugs the permeability of the skin for the drug needs to be higher than is 
needed for successful therapy; the rate of drug delivery can then be retarded by the 
TDS giving device controlled administration (2). Before discussing potential ways 
of achieving increased drug penetration through the skin a brief review will be 
given of the relevant aspects of skin structure and current views on the mechanisms 
of percutaneous absorption.
1.2 The Structure of Mammalian Skin
1.2.1 Skin Physiology
The skin is a multilayered organ which is highly complex in its nature. 
Macroscopically two distinct layers are apparent, the outer epidermis and the 
underlying dermis. Below the dermis lies the fatty subcutaneous tissue. The skin 























glands. The structure of mammalian skin is shown schematically in transverse 
section in Figure 1.1. The structure of the layers of the skin will now be described 
in more detail.
The dermis is approximately 3 to 5mm thick and so makes up the bulk of the 
skin (3). It consists of a matrix of connective tissue of fibrous proteins such as 
collagen and elastin. This network is embedded in an amorphous ground substance 
of which mucopolysaccharide makes up approximately 20% of the mass (4). These 
structural aspects makes the dermis very hydrophilic. The dermis contains the 
skin's blood supply, nerves and lymphatic systems. The vascular capillary network 
extends to just below the epidermis and provides a large surface area for exchange 
of materials between local tissue and the blood (5).
The epidermis is structurally far more complex than the underlying dermis 
and can itself be split into several layers. The epidermis can range between 0.06 -
0.8mm in thickness depending upon the body site and species (6 ). Functionally the 
epidermis comprises of the viable epidermis and the dead homy layer, the stratum 
comeum. The viable epidermis undergoes continuous differentiation as the cells 
rise to the skin surface. The cells change from metabolically active dividing cells in 
the stratum germivation, which is closest to the dermis, into flattened, dead, 
keratinized cells of the outermost layer the stratum comeum (7).
1.2.2 The Stratum Comeum
The stratum comeum is a highly specialized stmcture. It consists of layers 
of organised, flattened, keratinized dead cells. Over most areas of the body there 
are approximately 10-15 layers of such cells (8 ) producing an average thickness of 
about lOfxm. These cells are embedded in a continuous matrix of multilamellar, 
extracellular, lipid bilayers, the stmcture and composition of which is unique to the 
stratum comeum (9,10). In recent years these lipids have been extensively studied 
and characterised. These investigations have shown that the stratum comeum lipids 
consist mainly of nonpolar lipid species of which up to 50% are ceramides. The
other lipid classes identified as major components in these studies were cholesterol, 
free fatty acids, triglycerides and cholesterol sulphate (11-15). A high proportion of 
ceramides and free fatty acids have been shown to contain long unsaturated acyl 
chains up to C3 0  in length (14,15). These lipids form broad bilayers which have a 
high degree of crystallinity in their structure (16,17).
1.2.3 The Barrier Function of Skin
It has long been known that the skin's various layers were not equally 
permeable (18). Through a series of initiative deductions from observations of 
diseased and damaged skin and elegant biophysical experiments it was deduced that 
the main barrier to the permeability of the skin lay in the stratum comeum (18,19). 
The stratum comeum is not uniform throughout its depth. It has therefore been 
suggested that the lowest regions of the stratum comeum known as the stratum 
lucidium or compactum may be the greatest barrier to permeation by polar 
molecules (20). It has further more been shown that the key to this impermeability 
of the stratum comeum is the intercellular lipid lamellae. As described above 
( 1 .2 .2 ) these are present as broad crystalline bilayers of saturated lipids which 
provide a good barrier to diffusion (21-23).
1.3 Percutaneous Absorption
1.3.1 Routes of Penetration
When a penetrant molecule comes into contact with the skin it has two 
potential routes of penetration across the barrier layer. One is by the 
transappendageal route, that is down sweat ducts or hair follicles. The second route 
is by penetrating through the continuous stratum comeum. The transappendageal 
route has become known as the "shunt" diffusion pathway and is considered 
comparatively unimportant due to the relatively low surface area occupied by the 
structures involved (24). An exception to this is the diffusion of large polar 
molecules where this may be the only route available. Two pathways have been
proposed for the diffusion of molecules through the stratum comeum, the 
transcellular and the intercellular routes (24). These are shown on the schematic of 
the stratum comeum in Figure 1.2. It was suggested by Scheuplein and Blank (18) 
that as the lipid channels provide only a small fraction of the total volume of the 
stratum comeum most of the diffusion would be transcellular. More recent 
evidence has however shown that the intercellular channels may be far larger than 
first thought and epidermal lipid composition greatly affects permeation rates (25), 
thus implicating the intercellular route as a major pathway across the stratum 
comeum. By use of electron microscopy combined with autoradiography the 
permeation of compounds through the stratum comeum has been visualised (26-28). 
In these studies it was found that the majority of the permeant compounds 
accumulated in the intercellular spaces suggesting percutaneous absorption occurs 
primarily through the intercellular channels. The authors proposed that lipid soluble 
molecules would pass down the centre of the lipid bilayers whilst hydrophillic 
molecules would diffuse along water channels present between the polar headgroups 
of the bilayers.
1.3.2 The Kinetics of Percutaneous Absorption
If it is assumed that the stratum comeum is the major barrier to penetration 
of the skin (see 1.2.3) and the viable epidermis and dermis act as a perfect sink for 
any permeant (29), then the rate of percutaneous absorption will be limited by the 
permeability of the stratum comeum. There has been no reported evidence for 
active transport of permeants across the stratum comeum, penetration is thought to 
occur by passive diffusion. The permeation of drug molecules through the skin can 
be represented by Fick's first law of diffusion
J = DKg Equation 1.1
where J is the rate of transfer per unit area of membrane surface per unit time (the 



















skin, K is the membrane/vehicle partition coefficient and D is the diffusion 
coefficient of the drug in the membrane. From this equation it can be seen that the 
rate of flux can be increased by decreasing the thickness of the barrier layer or 
increasing either the concentration, the diffusion coefficient or the 
membrane/vehicle partition coefficient.
Commonly in studies of percutaneous absorption the cumulative amount of 
drug permeating the skin per unit area of membrane, M, is plotted as a function of 
time. These are known as Barrer plots. From the linear portion of this plot 
pseudosteady state flux values and rate constants can be obtained. A typical Barrer 
plot is shown for simple zero order flux in Figure 1.3. The lag time (3), may be 
obtained by extrapolation of the linear portion of the graph to the time axis.
1.4 Methods of studying Percutaneous Absorption
1.4.1 In-Vivo Techniques
In order to truly assess the percutaneous absorption of a drug into a living 
animal the permeation of that compound should ideally be determined in that 
species. However, particularly with man this approach is often fraught with 
experimental and ethical difficulties.
There are several methods of studying percutaneous absorption in-vivo. One 
commonly used approach is to use an indirect method by measuring radioactivity in 
excreta following topical application of the labelled compounds. This technique has 
been used by Feldmann and Maibach (30,31) to study the percutaneous penetration 
of radiolabelled compounds in man. In these studies the total radioactivity excreted 
in the urine was measured. This method has the problem that the drug may be 
metabolised in crossing the viable tissues. The body's organs may bind or store 
much of the absorbed drug and there are other routes of excretion. In order to try 
to correct for this the authors determined the amount of radioactivity excreted in the 
urine following parenteral administration of a bolus of drug. Even with this 
correction the method has its limitations and the interpretation of this type of data
MTime
Figure 1.3 A Barrer plot for the diffusion of drug through the stratum comeum. M 
is the cumulative mass of drug that has permeated the skin per unit area.
should be made carefully. The indirect method described above has also been used 
in many animal studies of percutaneous absorption (32,33). In these experiments 
measurements of both CO2  and fecal excretion can be obtained by use of a 
metabolic cage.
Another method of analysis of percutaneously absorbed substances is the 
determination of plasma concentration of the drug over a period of time. The area 
under the curve can be used as a measure of the amount of drug absorbed. This 
again can be carried out using radiolabelled drugs or substances that are easily 
assayed using chromatographic techniques. This method again suffers with 
problems due to drug metabolism and storage of the drug by the organs in the body.
An alternative approach in determining in-vivo percutaneous absorption is 
the surface recovery method. In this technique a drug dose is applied as a 
formulation and after a period of time the amount remaining on the skin surface is 
determined. It is assumed that the difference between the amount of drug applied 
and the amount recovered is the amount absorbed. This method has a problem in 
the fact that you can never be sure all the drug has been recovered. Also, drug may 
partition into the stratum comeum but may never be systemically absorbed, 
remaining in the comeum until it is sloughed off. This drug would not be 
accounted for by the surface recovery method leading to an over estimation of drug 
absorption.
The use of the biological or pharmacological response produced by the drug 
is another way of estimating the extent of percutaneous absorption. A good 
example of this is the vasoconstrictor test for steroids. Application of many steroids 
to the skin induce vacoconstriction of the superficial arteries and so causes 
blanching of the skin. This effect has been used as an assay for topical steroids 
since the early 1960's (34). This test has since been updated and standardised (3). 
However, in many cases it is still based on a subjective assessment of degree of 
palor of the skin by eye, which may lead to large variation between investigations.
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1.4.2 In-vüro Techniques
ïn-vivo studies would be expected to produce the best clinically relevant 
data, however in-vivo studies are expensive, suffer from ethical problems and can 
not be used to provide percutaneous absorption data for highly toxic compounds. 
With these aspects in mind many studies of percutaneous absorption are carried out 
in-vitro on excised human or animal skin.
The basis of in-vitro absorption studies is that the major barrier layer of the 
skin lies primarily in the stratum comeum. As this is composed of nonliving tissue 
and diffusion through it is a passive process (see 1.2.3 and 1.3.2) the rate of 
absorption in-vivo and in-vitro should be the same over a short time course before 
the excised skin decays. In-vitro studies are very simple compared with in-vivo 
work. They can therefore be carried out with less effort and in a greater number 
than in-vivo experiments, so are popular with many investigators.
Early in-vitro studies involved vertically mounted two chamber diffusion 
cells in which drug was applied in solution on one side of the membrane and the 
same solvent minus drug placed on the other side of the membrane (35). This 
technique however causes excessive hydration of the skin. The vertical cell has now 
largely been replaced by a horizontal cell with receptor fluid below the skin and the 
upper chamber (above the stratum comeum surface) left open to ambient conditions. 
These cells can be either static cells as described by Franz (36) or of a flow-through 
design (37).
In all in-vitro experiments care must be taken with drugs of low aqueous 
solubility. Lipophilic drugs may not partition from the stratum comeum into the 
aqueous viable epidermis or dermis. In-vivo the drug would be cleared from this 
site by the circulation. Also, if the drug has a higher solubility in the skin than the 
receptor phase then it will be unfavourable for the drug to partition into the receptor 
fluid. In both of these situations an artificial barrier will be created, the permeant 
will not be detected and a low estimate of percutaneous absorption will be obtained. 
The permeation rate in-vitro can thus be greatly affected by the receptor fluid
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especially for lipophilic compounds (38-40). Sink conditions must be available for 
the penetrating drug without the barrier properties of the skin being affected.
1.4.3 Animal Models for Human Skin
It is not always possible to obtain a reliable source of consistent human skin 
to carry out large numbers of permeability experiments which would be needed for 
structure activity studies. To get around this problem various animal models have 
been used in both in-vivo and in-vitro studies. Commonly the data from these 
studies are extrapolated to the human case. However, the validity of these 
extrapolations will depend upon the animal species used. There have been several 
studies carried out which compare the permeability of various animal skins to that 
of human skin. These have been carried out both in-vivo and in-vitro.
Bartek et al (41) compared the permeability of rat, rabbit, pig and human 
skins to six radiolabelled compounds in-vivo. The authors found that the 
permeability of the skin decreased in the following order, rabbit, rat, pig and man. 
The skin of the miniature swine had by far the closest permeability to that of human 
skin. Bronaugh et al (42) compared the percutaneous absorption of several 
substances through selected animal skins to that through human skin using an 
in-vitro technique. The relative permeability of the skins examined was dependent 
upon the permeant. For all compounds pig skin was observed as a better model for 
human skin. Similarly Marzulli et al (43) found that the skin of the weanling pig 
had the closest permeability to human amongst a range of common laboratory 
animals including chimpanzee and monkey to a series of chemical warfare agents. 
In a review of these studies Wester and Maibach (44) concluded that the animals 
most predictive of percutaneous absorption in man are the monkey and the pig. 
In-vitro studies (45,46) show whole rat skin to be a good model for human skin 
with polar molecules but not for lipophilic substances. This has been put down to 
the dermis acting as an artificial barrier to absorption. The use of epidermal 
membranes was suggested as a way around this. In a more recent study by the
12
same group porcine epidermal membranes were considered to be a better model for 
human skin (47).
1.4.3.2 Porcine Skin as a Model for Human Skin
In many of the studies cited in the previous section it was shown that 
porcine skin was a relatively good model for human skin in terms of its 
permeability characteristics. There has also been evidence that suggests that porcine 
skin is structurally similar to human skin. Bronaugh et al (42) found that porcine 
and human skin have the same hair follicle density, whereas that of the rat was 26 
times greater. Pig skin was however, measured as having a stratum comeum 15 
times thicker than man.
The barrier properties of the skin have been shown to be associated with the 
intercellular lipids of the stratum comeum (see 1.2.3). In particular the long acyl 
chain ceramides are implicated in the barrier function. Detailed analysis of these 
lipids from both human and porcine skin have shown that the glycosphingolipids 
and ceramides present in the stratum comeum of both species are very similar in 
structure and composition (48). It has recently been shown using a small angle x- 
ray scattering that the diffraction pattems obtained from the extracellular lipid
lamellae of human and porcine stratum comeum are very similar, demonstrating
good structural parity, whilst those from mouse skin are different (49).
1.5 Permeation Enhancement
1.5.1 Penetration Enhancers
At the start of this chapter it was stated that percutaneous absorption is 
hampered as a means of drug delivery by the impermeability of the skin, in 
particular the stratum comeum. One approach to overcome this and open up the 
route for the delivery of many drugs is to employ the use of chemical penetration 
enhancers. These can be defined as molecules which partition into the stratum 
comeum and interact with its constituents decreasing the resistance of the skin to
13
percutaneous absorption. The ideal characteristics of a penetration enhancer were 
listed by Barry (3). A condensed form of this list is given below. It is a very 
unlikely any single compound could have all of this spectrum of properties.
Ideal properties of a chemical penetration enhancer:
1. The enhancer should be pharmacologically and chemically inert.
2. The material should not be toxic, allergenic or irritating.
3. The onset of action of the enhancer should be immediate and reversible.
The integrity of the skins barrier function being completely returned when
the enhancer is removed.
4. The material should be a good solvent for drugs.
5. The material should be cosmetically acceptable.
6 . The materials should be relatively cheap.
Many compounds have been investigated for permeation enhancing activity. 
There have also been compounds specifically synthesised for use as penetration 
enhancers. These compounds can be seen to fall into one or both of two categories, 
the solvents and the surfactants. There are a few compounds such as urea which do 
not fall into either of these groups. Before looking at these compounds and their 
effectiveness a brief review will be given of the current theories of the mechanisms 
of action of chemical penetration enhancers.
1.5.2 Mechanisms of Action of Penetration Enhancers.
Although there have been many studies involving chemical penetration 
enhancers their exact mechanisms of action are yet to be fully elucidated. The 
different types of enhancer would be expected to have different modes of action 
upon the skin, this is also likely to vary from drug to drug. A brief review will be 
given of some of the current theories of permeation enhancement i.e. how 
enhancers affect the stratum comeum and it’s permeability.
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The permeation of a compound through the skin can be described 
mathematically by Picks Law of Diffusion (see 1.3.2). Looking at this equation 
it can be seen that there are two possible ways in which enhancers can act in the 
skin to increase drug flux. If the enhancer is a good solvent for the drug when it 
penetrates into the skin it may act as a cosolvent for the permeant in the skin. This 
will increase the stratum comeum: vehicle partition coefficient for the drug and thus 
increase the flux through the skin. The other way enhancers may act is to decrease 
the resistance in the barrier layer to diffusion of the drug. This will increase the 
diffusion coefficient of the permeant and hence its rate of absorption.
The highly structured, intercellular lipid lamellae are known to play a major 
role in the barrier function of the stratum comeum (1.2.3). By the use of 
differential scanning calorimetry (DSC) and Fourier transform infrared spectroscopy 
(FTIR) increases in skin permeation rates have been correlated to increased lipid 
fluidity in the stratum comeum (50-53). Fluidisation of the lipids apparently 
decreases the diffusional resistance of the membranes. This is the suggested major 
mechanism of action of many known penetration enhancers such as Azone, oleic 
acid and decamethyl sulphoxide (DCMS) which are thought to penetrate into the 
lipid bilayers, disrupt their packing and so increase lipid fluidity (50). This action 
would be expected to increase the permeation of hydrophobic compounds, but will 
also affect polar penetrants which at sometime in their passage through the stratum 
comeum will have to cross lipid bilayers (28).
Polar drugs are suspected as permeating the stratum comeum principly via 
aqueous regions between the lipid bilayer headgroups (see 1.3.1). Hydration of the 
skin would swell these areas and allow increased flux of drug along these channels. 
Enhancers may also act in these regions by increasing hydration dismpting the 
packing of bound water in the hydration spheres around the lipid headgroups, or 
replacing this water. This would allow increased diffusion of polar permeants 
(28).
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Many enhancers such as DCMS and sodium lauryl sulphate and urea may 
interact with the keratin of the stratum comeum allowing increased permeation 
through or around the comeocytes and reducing possible dmg binding sites (54). 
Many compounds will also have effects in the topical vehicle increasing the 
thermodynamic activity or the bioavailability of the dmg, thereby increasing 
permeation rates. Although this is observed as penetration enhancement there is no 
action on the skin and so does not fit the criteria as defined in 1.5.1. It is thought 
that most enhancers will act by a combination of the above suggested mechanisms.
1.5.3 Solvents as Penetration Enhancers
There are many compounds that have been investigated for penetration 
enhancing activity that can be regarded as solvents. Water is the most simple of 
these compounds and one which complies with many of the criteria stated above 
(see 1.5.1). Hydration of the stratum comeum, usually achieved by occlusion of 
the skin surface, generally causes a large increase in the permeability of the skin. 
These effects have been demonstrated for many permeants, both in-vivo (55) and 
in-vitro (56). Lipid removing solvents such as chloroform: methanol mixtures and 
hexane cause dramatic increases in skin permeability but these effects are 
irreversible and inflict damage upon the skin (57). These cannot be seen to be 
suitable for use as penetration enhancers. Dimethyl sulphoxide (DMSO) has been 
known for many years to increase the percutaneous absorption of various chemicals 
in a reversible fashion (3). It is unlikely however, that a clinical application will be 
found for DMSO due to potential toxicological problems. Other solvents used as 
enhancers include ethanol (53) and propylene glycol which is known to enhance the 
permeation of steroids (58). Propylene glycol also displays a synergistic action 
when used with other penetration enhancers such as 1 -dodecyl azacycloheptan-2 - 
one, Azone (59).
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1.5.4 Surfactants as Penetration Enhancers
1.5.4.1 Classification of Surfactants
Molecules which have an amphipathic nature, i.e. they possess both 
hydrophilic and hydrophobic groups, will often display surface activity. The 
hydrophobic portion of surfactants usually consists of alkyl or acyl chains. The 
hydrophilic 'head' group may be charged or uncharged. The classification of 
surfactants into three major groups is based upon the charge of the headgroup. 
Thus, surfactants can be anionic (e.g. sodium dodecyl sulphate), cationic (e.g. 
cetyltriacetyl ammonium bromide) or nonionic, where the polar headgroup is 
normally a polyoxyethylene chain (e.g., nonylphenol ether polyethoxylate).
1.5.4.2 Ionic Surfactants as Penetration Enhancers
A number of anionic and cationic surfactants have been shown to act as 
enhancers of percutaneous absorption (60). The activity of these surfactants may be 
due to their ability to interact with and possibly extract the skin lipids. Anionic 
surfactants are also known to interact strongly with the protein in the stratum 
comeum. However, both anionic and cationic surfactants are unlikely to find a use 
in transdermal drug delivery as enhancers of permeation as both are reputed as 
having irritation potential (61).
1.5.4.3 Nonionic Surfactants as Penetration Enhancers
1.5.4.3.1 Structure of Nonionic Surfactants
Nonionic surfactants are known to be the least irritating to the skin of the 
three classes of surfactant and as such, have the greatest potential for use as 
enhancers. Although there are many types of nonionic surfactants the majority of 
studies has been limited to four principle series. These are the polysorbates, esters 
or partial esters of sorbitol condensed to ethylene oxide chains; polyoxyethylene 
alkyl ethers and esters, polyoxyethylene alkylphenols and poloxamers
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(polyoxyethylene polyoxypropylene copolymers). The generalised structues of each 
of these types of surfactants are given in Figure 1.4.
1.5.4.3.2 The Effect of Nonionic Surfactants on Percutaneous Absorption
In order to exert an effect in the skin the surfactant must first itself 
penetrate into the stratum comeum. The rate of penetration of polyoxyethylene 
surfactants into the skin is generally quite low, although some possess a greater 
intrinsic rate of permeation than their anionic counterparts (62). There are many 
variables which will affect the extent of permeation of the surfactant and hence its 
potency as an enhancer. The vehicle used to deliver the drug and enhancer to the 
skin surface will affect the partitioning behaviour of the enhancer and possibly the 
physical characteristics of the skin. The degree of enhancing activity is also 
strongly dependent upon the surfactant structure and concentration (60,63). 
Therefore, attempts to correlate data from different sources proves to be very 
difficult with each investigator using different systems and a variety of different 
anatomical sites of application and animal species (11,44). Surfactants have been 
shown to enhance, retard or have no effect upon skin permeability. This is 
dependent upon how they are used and in what concentration (60).
The polysorbates have been shown to increase percutaneous absorption in 
several studies. Polysorbates 20, 40, 60 and 80, when present in low 
concentrations <0.5% caused increased flux of both hydrocortisone and 
lidocaine through hairless mouse skin from a propan-2 -ol/H2 0  vehicle (64-66). 
When used in conjugation with propylene glycol (PG) the extent of enhancement 
was increased significantly suggesting some synergism between the PG and the 
surfactants. Polysorbates have been shown to increase the permeation of salicylic 
acid, sodium salicylate and flufenamic acid through rabbit skin, in-vivo from white 
petroleum bases containing 5 or 10% DMSO (67,68), as with PG, some synergism 
was observed between DMSO and the surfactant. Polysorbate 80 increased the 















Ryan (70) observed that polysorbate 85 increased the transepidermal water loss 
from excised rabbit skin. All these studies show the polysorbates affect the skin's 
barrier layer, however, polysorbate 2 0  had no effect on the absorption of naloxone 
through human skin (71) and similarly polysorbate 60 had little effect on the 
permeation of naproxen through rat, rabbit or human skin (72). From these studies 
it was not possible to form any definite quantitative structure-activity relationships 
for the polysorbates as permeation enhancers.
Polyoxyethylene aryl ethers are known to have potent membrane disrupting 
activity and are widely used as solubilising agents for membrane bound enzymes 
(73). Despite this there is little evidence to show these surfactants will act as 
enhancers of percutaneous absorption. Walters et al (74) found that the rate of skin 
permeation of methyl nicotinate across mouse skin was unaltered by both octyl and 
nonylphenol decaethoxylates. The aryl ethers can also retard the percutaneous 
absorption of compounds. Dalvi and 2^tz (75) observed that micellar 
concentrations of nonylphenol pentadecaethoxylate considerably reduced the 
permeation of benzocaine through hairless mouse skin. It has been reported 
elsewhere that the damage potential upon the skin from anionic surfactants is 
reduced by the presence of long ethoxy chain acyl ethers (76). The nonionic 
surfactant presumably reduces the absorption of the ionic surfactant.
As with the other classes of surfactants there are conflicting reports about the 
poloxamers. Members of the poloxamer series had little effect on the flux of 
naloxone through human cadaver skin in-vitro (71). However, poloaxamers 231 
and 182 significantly increased the flux of salicylic acid and sodium salicylate 
through rabbit skin (67).
Polyoxyethylene alkyl ethers and esters have been shown to enhance the 
percutaneous absorption of many compounds and appear to be the most potent 
enhancers amongst the nonionic surfactant classes. The efficacy of these surfactants 
was very structure dependent and several structure activity studies have been carried 
out. Walters et al (74,77) studied the effect of a wide range of alkyl ether
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ethoxylates, which varied in both alkyl and ethylene oxide chain lengths, upon the 
permeation of methyl nicotinate through hairless mouse skin in two chambered 
diffusion cells. They found that the surfactants with a linear alkyl chain length 
greater than Cg and ethoxy chain length of less than significantly increased the 
permeation of methyl nicotinate. Maximum enhancement was achieved with Brij 
36T (C1 2 E 1 0 ) followed by Brij 96 (Cig=Eio), Brij 56 (C1 5 E1 0 ) and Brij 52 (CjgEg). 
The effectiveness of Brij 36T as an enhancer upon the permeation of both hexyl and 
methyl nicotinate has been noted by other investigators (78,79). In a study of the 
effects of fifteen nonionics on the permeation of sodium salicylate and salicylic acid 
through rabbit skin in-vitro significant enhancement was obtained with Brij 30 
(C 1 2 E4 ) and Cig=E 2  (63). CigE2  was also shown to be a good enhancer for 
flufenamic acid in the same test conditions (6 8 ). The flux of naloxone was 
enhanced by lauryl alcohol (C1 2 E0 ), and C 1 2 E4  but C1 2 E2 0  had little effect (71). 
Also in this latter study it was observed that the dodecyl (C1 2 ) chain was often the 
optimum alkyl chain length for enhancement with both nonionic and ionic 
surfactants. Other work showed Cig=Eg to enhance the permeation of nitroglycerin
(80) and that C1 2 E2  enhanced the flux of both theophylline and adenosine in-vitro
(81). As discussed earlier it is difficult to correlate these data due to differences in 
experimental procedures between studies.
Azone was synthesized for use as a permeation enhancer. It can be regarded 
as a fairly lipophilic nonionic surfactant. Azone is reported as having very good 
enhancing activity with a number of compounds such as narcotic analgesics (82), 5- 
flurouracil (83) and anxiolytics (84).
1.5.4.2.3 The Effect of Nonionic Surfactants on other Biological 
Membranes
The skin can be regarded as a very complex biological membrane. If it is 
assumed that the barrier function of the skin is related to the structuring of the 
intercellular lipid bilayers then the effects that compounds have on other natural or 
synthetic lipid bilayers may indicate their potential as skin permeation enhancers.
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Nonionic surfactants are known to interact strongly with membranes and 
several structure-activity studies have been undertaken to find the optimum 
physiochemical characteristics for surfactant membrane activity. In a study upon 
the mobility of the protozoan Tetrahymena elUottij Baillie et al (85) observed that 
with octyl and nonylphenol based surfactants, as the ethoxy chain length increased 
the surfactant potency upon the membrane decreased. A similar observation was 
made for the alkyl ether ethoxylates where the most potent effects amongst all the 
surfactants studied were seen with C1 2 E4 . The polysorbates investigated were far 
less effective. Structure-activity relationships similar to those described above for 
the alkylphenol ether ethoxylates were obtained with similar surfactants by Gadd 
and Curtis-Prior (8 6 ) working on spermatozoon membranes and Levin (87) who 
studied effects on rat vaginal membranes.
In a review of the interactions of alkyl and aryl polyoxyethylene ethers 
Florence et al (63) concluded that optimum biological activity was often obtained 
with a C1 2  hydrocarbon chain. The ability of this chain to penetrate membranes and 
the depth of penetration will be affected by the ethoxy chain length. For many of 
the investigations reviewed an ethoxy chain length < Ej2  gave the most active 
surfactant.
1.6 Objectives of this Work
A quantitative structure-activity study will be made of the membrane 
fiuidising activity of a homogogous series of pure dodecyl ether ethoxylates 
Ci2 Eo"Ci2 ^ *  These surfactants are all of single ethoxy chain length and so differ 
from the polydisperse surfactants used in many other studies of this type. 
Distearoylphosphatidylcholine (DSPC) liposomes contain bilayers of structured 
lipid. These will be used as a simple model of the intercellular lipid lamellae of the 
stratum comeum in order to investigate bilayer fluidisation by the nonionic 
surfactants. Physical changes in the bilayers will be quantitatively assessed by 
differential scanning calorimetry (DSC), fluorescence polarisation spectroscopy 
(EPS) and electron spin resonance (ESR). The effects of the surfactants upon
2 2
extracted skin lipids and whole stratum comeum will be made using DSC and ESR. 
Finally, penetration enhancement studies on the permeation of both polar and 
nonpolar steroids through porcine skin in-vitro will be carried out using the same 
series of surfactants. Attempts will be made to correlate the permeation data to the 
physical fluidisation studies. This will hopefully lead to further insight into the 





2.1 Acquisition and Storage of Porcine and Human Skin
Whole porcine ears were obtained from a local abatoir within 15 minutes of 
slaughter. The ears were washed with copious cold tap water and blotted dry. The 
whole skin from the back of the ear was carefully dissected and peeled away from 
the ear cartilage. The skin was laid flat and the hair carefully shaved from the skin 
before rewashing the skin with cold tap water. The skin was blotted dry and 
pressed flat, stratum comeum uppermost onto aluminium foil. The samples were 
then sealed into plastic bags and stored frozen at -2 0 ®C until required.
Whole human cadaver abdominal skin was obtained from autopsy. Samples 
were from Caucasian subjects in the age range 30-70 years old. Upon receipt of the 
samples the subcutaneous fat was removed by blunt dissection. The skin was then 
stored flat on aluminium foil at -20®C as described above.
2.2 Water and Buffers
2.2.1 Distilled Water
Distilled water used in experimental protocols and for the preparation of 
buffers was freshly distilled from an all glass apparatus.
2.2.2 Phosphates Buffered Saline (PBS) pH 7.4
Phosphate buffered saline pH 7.4 was prepared using the formula stated 
below. All buffer salts used were of reagent grade obtained from BDH chemicals 
Ltd (Poole, UK) and were used in their anhydrous form.
KH2 PO4  1.36g
Na2 HPÛ4  6.90g
NaCl 4.59g
Distilled water to 1000ml
Prior to finally making up to volume the pH of the buffer was adjusted to 
exactly pH 7.4 with 0.02M NaOH.
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2.2.3 Borate Buffer pH 8.8
Clark and Lubs (8 8 ) borate buffer was used in the ESR studies, the formula 
for which is given below:






to 1 0 0 0 ml






to pH 8 .8 , approx 16.3ml. 
to l(X)ml
2.3 Glassware
2.3.1 Standards and Suppliers
Whenever possible grade A volumetric flasks and glass pipettes were used. 
The 1.5 and 4.5ml vials used in many experiments were obtained from Chromacol 
(London, UK).
2.3.2 Cleaning of Glassware
The glass vials were supplied acid washed and so were used without further 
cleaning. For the physical measurements of lipid bilayer fluidisation by nonionic 
surfactants it was important to avoid contamination from other detergents. The 
glassware used was therefore routinely soaked in chromic acid for > 4  hours, 
usually overnight, before being thoroughly rinsed with distilled water. At least 10
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changes of distilled water were used. The glassware was then oven dried before 
use.
2.4 Nonionic Surfactants
Two types of nonionic surfactants were used in these studies, aryl ether 
ethoxylates based upon nonylphenol and alkyl ether ethoxylates based upon either 
decanol or dodecanol. All surfactants were used as supplied.
2.4.1 Nonylphenyl Ether Ethoxylates
The nonylphenyl ether ethoxylates used in this study were polydisperse, each 
surfactant contained a mixture of ethylene oxide chain lengths. These surfactants 
will be refered to as NPX, where X is the average number of ethylene oxide groups 
condensed to the nonylphenol moiety as stated by the manufacturer. The general 
surfactant structure is shown in Figure 1.4 In order to obtain a large range for a 
homologous series of these surfactants it was necessary to obtain samples from 
greater than one supplier. The supplier and the surfactant trade names are given in 
Table 2.1.
2.4.2 Alkyl Ether Ethoxylates
The alkyl ether ethoxylates used during this study were based on either 
decanol or dodecanol, these will be refered to as CjoEn respectively where
n = the number of ethoxy groups condensed to the straight chain alcohol as stated 
by the supplier. For the Brij series surfactants n refers to an average ethoxy chain 
length. The general structure of these surfactants is shown in Figure 1.4.
The decyl ether ethoxylates C1 0 E3 -C1 0 E5  and the dodecyl ether ethoxylates 
C1 2 E1 -C1 2 E8  were obtained from the Nikkol Chemical Company (Tokyo, Japan) 
Dodecanol C 1 2 E0  was from BDH Chemicals Ltd (Poole, UK) and was stated as 
having 99% purity. Brij 30 nominally C1 2 E4  was obtained from ICI Speciality 




Trade Name Supplier Ethoxy 
Chain Length®
NPO Nonylphenol 1 -
NPl Ethylan NPl 2 1.33+0.2



















NP7 Dowfax 9N7 3 7.10+0.31
NFS Arkopal N-080 5 8.15+0.35
NP9 Ethylan BCP 2 9.23+0.48






N Pll Arkopal N-110 5 10.88+0.24
NP12 Dowfax 9N12 3 12.97+0.38
NP15 Arkopal N-150 5 14.56+0.26
Table 2.1 Suppliers, trade names and calculated average ethoxy chain lengths of 
the nonylphenyl surfactants 
® Determined by ^H-NMR (mean ±range, n=2)
Key to suppliers
1. Aldrich Chemical Company (Gillingham U.K.)
2. Lambro Chemical Company (Eccles, UK)
3. The Dow Chemical Company (Hounslow, UK)
4. CargoFleet Chemical Company Ltd (Stockton,UK)
5. Hoechst UK Ltd. (Hounslow, UK)
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The Sigma Chemical Company (Poole, UK), the second sample was a gift from 
Fisons Pharmaceuticals (Loughborough, UK).
2.4.3 Methods of Analysis of Surfactants
To determine the chemical purity and the average ethoxy content of the 
polydisperse surfactants each sample was analysed by gas chromatography - mass 
spectrometry (GC-MS) and NMR. In addition to this the melting points of the 
Nikkol dodecyl ether ethoxylates were determined by differential scanning 
calorimetry (DSC).
2.4.3.1 Gas Chromatography - Mass Spectrometery (GC-MS)
The surfactants were dissolved in HPLC grade ethyl acetate to produce 
solutions of Img ml'^ concentration. These were run on a Hewlett Packard 
HP59970C gas chromatograph with mass selective detection using the following GC 
run parameters:
Column HPl
Initial oven temperature 55 ®C
Time at Initial temperature 0.50min
Ramp rate 15®Cmin-i
Final temperature 280®C
Time at final temperature up to 30 min
Injection volume 2 /xl
-1
The GC chromatographs and mass spectrometer fractionation spectra were 
analysed on the Hewlett Packard software supplied. Where possible the library of 
stored spectra supplied with the software was used to identify components.
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2.4.3.2 Proton NMR
The technique of analysis of polyethoxylated aryl and alkyl ether nonionic 
surfactants was adapted from methods used by other investigators (89-91). Samples 
of surfactant as 20-40 ^ /v  solutions in CDCI3  were analysed on a Jeol GX270 FT 
spectrometer operating at 270 MHz using tetramethylsilane (TMS) as an NMR 
reference point. The spectra and integrals obtained were an accumulation of 64 
scans.
2.4.3.3. Determination of Melting Points by DSC
The principles of differential scanning calorimetry and techniques of analysis 
of DSC traces are described in Chapter 3 of this thesis. For the analysis of 
surfactants, 5 mg sample of pure surfactant was accurately weighed into hermetically 
sealed DSC pans. The samples were then scanned over a standard heating run 
between -20 and 80°C at 5°C mim  ^ on a Dupont 910 DSC with 9900 thermal 
analyser. The DSC had been previously calibrated with distilled water and indium 
(see 3.2.8). The surfactant melting temperatures (T^ )^ were obtained directly from 
the traces produced.
2.4.4 Results of Surfactant Analyses
2.4.4.1 GCMS
2.4.4.1.1 Nonylphenyl Ether Ethoxylates
The nonylphenyl based surfactants produced complex chromatographs. The 
mass spectra taken from these peaks was used for peak identification and this was 
aided by searching for expected molecular ions. Figure 2.1 shows the GC 
chromatographs for NPO, NP2 and NP4. Complex groups of peaks eluted after 
various times up to 25 minutes. The probable identity of these peaks was 
determined by molecular ion searches and is given in Table 2.2. Nonyl phenol, 
NPO, was found to be multicomponent. This was most likely due to the presence of 
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Figure 2.1 Typical GC chrom atographs for three nonylphenol ether ethoxylates. 
a) NPO b) NP2 c) N P4.
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Elution time (min) Largest ion Peak identity





2 0 .8 -2 2 . 2 440 NP5
Table 2.2 Peak elution times, the largest detected ion and suspected peak identity 
for nonylphenyl ether ethoxylates analysed by GC-MS.
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tetraethoxylated compounds were also multicomponent presumably due to the same 
reason. From the data obtained it can be seen that NP2 contained NP1-NP3 and 
traces of NP4. However, above NP4/5 poor elution from the column and sample 
tailing prevented detailed analysis of these and higher molecular weight surfactants.
2.4.4.1.2 Alkyl Ether Ethoxylates
The dodecyl ether ethoxylate surfactants C1 2 E0 -C1 2 E8  all produced single 
peaks on the GC chromatograph. The trace shown in Figure 2.2 is for C1 2 E5 , 
similar chromatographs were obtained for the other surfactants of the series. As the 
molecular weight of the surfactant increased so did the elution time for the 
compound. This lead to some tailing of the peaks and caused them to become 
broader and flattened. The elution times of the surfactants C1 2 E0 -C1 2 E8  are given in 
Table 2.3.
The mass spectra observed were in parity with results obtained by McDonald 
and Robinson (89) who worked with similar compounds. Molecular ions were 
identified for all surfactants. Other peaks were consistant with the loss of -CH2  and 
-CH2 CH2 O units or multiples there of, i.e. peaks at M-14, M-28, M-44, M- 8 8  etc. 
Dodecanol C1 2 E0  and C 1 2 E 1 produced mass spectra which were homologous with 
those stored for these compounds in the software of the computer further 
comfirming the identity of the peaks.
The GC chromatograph for Brij 30 was far more complex and showed the 
surfactant to be polydisperse (Figure 2.3). From the analyses of the pure Nikkol 
surfactants it was possible to identify many of the peaks on the Brij 
chromatographs. Components were identified corresponding to C1 2 E0 -C1 2 E5 , 
however, it was thought that due to tailing higher ethoxylated surfactants may have 
not been detected. A sample was therefore analysed using a faster temperature 
ramp rate. From the resulting chromatograph C1 2 E6  and C1 2 E7  were also detected. 
A set of peaks of slighty lower retention time were observed shadowing those of the 
dodecyl ethoxylates. These were believed to be due to ethoxylates of another alkyl 








Figure 2 .2  GC chrom atograph for the Nikkol dodecyl ether ethoxylate, C 1 2 E 5 .
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Surfactant Molecular weight Elution time (min)
^ 1 2 ^ 0 186 9.18
^ 1 2 ^ 1 230 10.55
C 1 2 E2 274 11.76
C1 2 E3 318 12.92
C 1 2 E4 362 14.54
C1 2 E5 406 17.06
C 1 2 E6 450 21.43
C1 2 E7 494 28.76
C^Eg 538 32.22
Table 2.3 The molecular weights and GC elution times of the dodecyl ether 
ethoxylate surfactants.
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6 . 0 E 8
. 0E6
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2 . 8 E 6
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5 . 0 E5 -
^  3 . 0 E 5 -
Figure 2 .3  GC chrom atographs for a) Brij 30 b) Brij 36T.
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The chromatographs for the two samples of Brij 36T were even more 
complex than that for Brij 30. The chromatograph for the Fisons donated sample is 
shown in Figure 2.3. Surfactants in the range C1 2 E0 -C1 2 E8  were identified. There 
were also many other peaks presumably due to other alkyl chain length alcohol 
ethoxylates. The Sigma sample had fewer peaks of low retention time and more 
between 18-24 minutes. As with Brij 30 runs using higher ramp rates were used to 
attempt to resolve longer ethoxylate peaks, however, no compound larger than 
C1 2 E9  was detected.
2.4.4.1.3 Azone
The GC chromatograph for Azone showed a single peak that eluted after
11.1 minutes. This demonstrated that the sample was pure. Azone is of similar 
molecular weight to C1 2 E2  and its elution time indicated that it of a similar polarity 
to these surfactants. The mass spectrum was typical of a compound of its type.
2.4.4.2. Proton NMR
2.4.4.2.1 Nonylphenyl Ether Etholylates
Figure 2.4 shows a typical NMR spectrum for an alkylphenol ether 
ethoxylate, in this case NP5. There were three well separated groups of lines in the 
spectrum. The lowest field group (6 .8-7.3 ppm) was due to protons on the aromatic 
ring. The middle grouping (3.5-4.3 ppm) was from the protons of the ethylene 
oxide chain. The proton of the terminal hydroxyl was observed slightly upfield 
from this (3.3 ppm). The complex high field grouping (0.4-1. 8  ppm) was from the 
protons of the alkyl side chain. Similar spectra were observed for alkyphenol ether 
ethoxylates by Flanagan et al (90) and Crutchfield er û/ (91).
Printed above the spectrum is the integrals for each group of lines; each step 
is a quantitative measure of the number of protons giving rise to the signal. Since it 
is known that the total aromatic signal came from four protons (2 x2 ) the average 





















average number of ethoxy groups in the chain was then calculated by dividing this 
by four.
The average ethoxy chain length was determined, by the above method for 
the series of surfactants NP1-NP15. The results of these analyses are given as 
mean±range, n=2, in Table 2.1. The alkyl chain length or conformation was not 
determined as it was deemed to be too complex.
2.4.4.2.2 Alkyl Ether Ethoxylates
Figure 2.5 shows a typical NMR spectrum for an alkyl ether ethoxylate, 
in this case C1 2 E5 . There were two groups of lines in the spectrum. The low field 
peak (3.4-3. 8  ppm) was due to the protons of the ethoxy chain and the -CH2  group 
of the alkyl chain next to the oxygen. The terminal hydroxyl was slightly upfield 
from this peak (3.25 ppm). The other group of lines at a higher field (0.8-1.2 ppm) 
was due to the protons of the alkyl chain. The three protons of the terminal methyl 
group (-CH3 ) can be clearly identified at the high field end of the group (0.8 ppm). 
Similar spectra were obtained for other alkyl ether ethoxylates by Flanagan et al 
(90) and McDonald and Robinson (89).
As with the alkylphenol ether ethoxylates the number of protons in the 
ethoxy chain was calculated by measuring the height of their integral relative to the 
height produced by a known number of protons; in this case the three of the 
terminal methyl group of the alkyl chain. In a similar fashion the length of the 
alkyl chain can also be calculated. The average ethoxy and alkyl chain lengths for 
Brij 30 and Brij 36T are given in Table 2.4. For the Brij surfactants the results are 
mean±SD, n=5. For all the Nikkol surfactants C1 2 E 1 -C1 2 E8  
both alkyl and ethoxy chain lengths were as stated by the supplier.
2.4.4.S Melting Points Determined By DSC
All the dodecyl ether ethoxylates, C 1 2 E0 -C1 2 E8  gave a sharp melting 
































Brij 30 12.3±0.21 4.0610.34 14 Eo-By
Brij 36T1 12.910.28 7.8510.54 31 Eo-E,
Brij 36T2 12.1510.45 9.2710.28 18 Eo-E,
Table 2.4 Alkyl and ethoxy chain lengths of Brij surfactants determined by 
NMR and the surfactant purity determined by GC-MS.
determined by NMR (mean±SD, n=5) 
number of major peaks on GC chromatograph 
range of surfactant components identified by GC-MS 
sample from Fisons 
sample from Sigma
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the surfactants are shown plotted as a function of ethylene oxide chain length of the 
molecule in Figure 2.6. Looking across the series of surfactants from C1 2 E0 -C1 2 E8  
the melting temperature decreased form C 1 2 E0 -C1 2 E3 , a minimum was observed 
with C 1 2 E3 . From C 1 2 E3 -C 1 2 B8  as the ethoxy chain length of the surfactant 
increased so did the melting point of the surfactant.
2.4.5 Conclusions
2.4.5.1 Nonylphenyl Ether Ethoxylates
From the results obtained from both the ^H-NMR and the GC-MS analyses 
it can be seen that the nonylphenyl based surfactants were complex mixtures of 
surfactants being polydisperse in both ethylene oxide chain length and in the 
isomeric form of the nonyl chain. The ^H-NMR analyses showed the average 
ethoxy chain length of all the surfactants to be close to that stated by the supplier in 
general < ±0.5 ethoxy units. By use of GC-MS it was possible to show the 
polydispersity of the surfactants but this power of this technique was restricted to 
low molecular weight compounds.
2.4.5.2 Alkyl Ether Ethoxylates
The Nikkol supplied decyl and dodceyl ether ethoxylates were all shown to 
be pure and of the ethoxy chain length stated by the supplier. It would be expected 
that as the molecular weight of the surfactants increased that the melting points of 
the surfactants would also increase, however, from C 1 2 E0 -C1 2 E3  the melting point 
decreased. This may indicate that over this range surfactants the crystalline packing 
of the molecules in the solid state decreased.
The Brij surfactants were shown to be polydisperse both in ethoxy and alkyl 
chain length. The average ethoxy chain length of the sample of Brij 30 was close 
the value stated by the supplier, however, that was not the case for the samples of 
Brij 36T. The sample obtained from Sigma had an average ethoxy chain length of 
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Figure 2.6 The melting points of the dodecyl ether ethoxylates, as determined by 
DSC, plotted as a function of surfactant ethoxy chain length.
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ethoxy groups less than the stated Ci2 Eio- This difference between the two samples 
was verified by their GC chromatographs.
2.5 Materials used in the DSC Studies 
Distearoylphosphatidylcholine (DSPC) stated as >99% purity was obtained
from Sigma (Poole, UK). The DSPC was shown to be chromatographically pure 
and produced a single spot when analysed by thin layer chromatography (silica gel 
G; solvent: chloroform:methanol 2:1). The DSPC was used without further 
purification.
The chloroform used in these studies was freshly distilled from an all glass 
distillation apparatus prior to use to remove any contaminants. Trypsin used in the 
preparation of stratum comeum was bovine type III trypsin prepared from bovine 
pancreas, this was obtained from Sigma (Poole, UK). 1 -dodecyl-aza-cycloheptan-2- 
one (Azone* )^ was kindly donated by Fisons Pharmaceuticals (Loughborough, UK). 
This was shown to be pure when analysed by GC-MS. Hexane, methanol, KCl, 
CUSO4  and absolute ethanol were of reagent grade and obtained from BDH 
Chemicals Ltd (Poole, UK). These were used as supplied.
2.6 Materials used in the FPS Studies
DSPC, chloroform and Azone were as described above (2.5). Four 
fluorescent membrane probes were used in the FPS study. Cis-parinaric acid (cis- 
pna), and 8 -anilino-1 -naphthalene sulphonic acid (ANS) were obtained from Sigma 
(Poole, UK). The cis-pna was stored in absolute ethanol, under helium, at -80°C to 
prevent oxidation. Perylene and 1,6-diphenylhexatriene (DPH) were obtained from 
Aldrich (Gillingham, UK). These were used as supplied. The chemical structures 
of all four probes are shown in Figure 2.7. Glycogen and 2,6-di-t-butyl-4 methyl 
phenol (BHT) were both obtained from Sigma (Poole, UK). The acetone used was 














grade. All three were obtained from BDH Chemicals Ltd (Poole, UK). All these 
solvents were used as supplied.
2.7 Materials used in the ESR Studies
DSPC, chloroform, acetone and ethanol were as described above. The spin 
probe, 5-doxyl stearic acid (5-DS) was obtained from Sigma (Poole, UK) and this 
was stored in absolute ethanol under helium at -80®C. The silica quartz capillary 
tubing used to make the sample tubes was obtained from Jencons Scientific 
(Leighton Buzzard, UK).
2.8 Materials used in the Permeation Studies
The i^C-hydrocortisone, i^C-oestradiol, ^^C-progesterone and i^C-oestrone 
used as permeants in these studies were obtained from Amersham International pic 
(Amersham, UK). The structures of these steroids is shown in Figure 2.8. The 
steroids were all labelled at the four position in the steroidal ring, as shown by the 
asterisk. All had specific activities of 2.07GBq mmok^ (56mCi mmok^) and were 
stated as having radiochemical purities between 99.7 and 99.9 percent. The steroids 
were stored at -20°C and used without further purification. Unlabelled steroids 
were obtained from Sigma (Poole, UK) and used as supplied. The steroids were 
prepared as solutions in acetone. A ratio of hot to cold steroid of 1:200 was used 
for all four compounds. Optiphase^ scintillation fluid was from Pharmacia 
(Uppsala, Sweden). The glass diffusion cells, underwater magnetic stirrers and stir 
bars were all kindly donated by Fisons Pharmaceuticals (Loughborough, UK).
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Figure 2.8 Chemical structures of the four radiolabelled ^^C-steriods used in the 
skin permeation studies. The position of the label is shown by an asterisk.
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CHAPTERS
MEASUREMENT OF LIPID BILAYER FLUIDISATION 
BY DIFFERENTIAL SCANNING CALORIMETRY
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3.1. INTRODUCTION
3.1.1 Principles of Differential Scanning Calorimetry (DSC)
DSC is used mainly for the study of physical transitions. It is a basic 
thermal analysis technique which can be defined as "a technique in which the 
difference in energy input into a substance and a reference material is measured as a 
function of temperature whilst the substance and reference material are subjected to 
the same controlled temperature programme” (92). Typical DSC equipment is 
illustrated schematically in Figure 3.1. Sample and reference are heated at identical 
predetermined rates. In the event of a transition occurring thermal energy (power) 
is added or subtracted from the sample or reference in order to maintain isothermal 
conditions. The differential energy is equivalent to the energy absorbed or evolved 
in the particular transition (93).
3.1.2 DSC of Biological Membranes
Historically DSC has been used to study the thermally-induced transition 
from a relatively ordered gel-crystalline state at lower temperatures to a relatively 
disordered fluid liquid-crystalline state at higher temperatures in model lipid 
bilayers and biological membranes (94). This thermotropic transition can, for pure 
lipids be viewed as a simple two state, first order, endothermie process (95).
A typical DSC trace for such a transition is shown in Figure 3.2. From such 
a transition profile a number of important parameters can be determined directly. 
The phase transition temperature, denoted T^, is the temperature at which the 
excess specific heat required for the transition reaches a maximum. The peak area 
is equal to the enthalpy of the transition (i^cai) can be determined by 
integration of the peak when the calorimeter has been calibrated with a known 
standard. The sharpness of the transition is often expressed as the width, in degrees 
Kelvin, at half peak height (ATi^ ). This value may range from 0.2K for very pure 
synthetic lipids (96) to as much as 15-20K for biological membranes (97).
49
T h erm o elec tr ic  disk  
\  (constantan)
G a s  purge inlet
S a m p le  c h a m b e r  ,
S i lv er  ring  
R efer e n c e  pan Sam p le  pan
Chrom el w a fer
e rm o c o u p le  jun ct ion
A lu m el  wire
C hrom el wireHealing block




Figure 3.2 Typical DSC trace of a first order melt endotherm showing the 
transition midpoint temperature (T^ )^ and the peak width at half peak height (AT,^).
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From these measurements more complex information can be obtained. The 
Van't Hoff enthalpy can be determined from the relationship.
AHvh = 4RT^VAT.^ (95)
where R = Universal Gas Constant 
AT,  ^and T^i are in Kelvin.
The cooperative unit (CU) of the transition expressed as a number of 
molecules can be calculated from the ratio AMy^/ARç^ i. The CU is a measure of 
the degree of intermolecular cooperation between phospholipid molecules in a 
bilayer. For a completely cooperative first order transition of a pure substance the 
CU should approach infinity, while for a non-cooperative process the value should 
approach unity. (94)
Early work with DSC by Chapman and co-workers (98) and Hinz and 
Sturtevant (96) produced valuable information concerning the thermotropic phase 
transitions of single chain length 1 ,2 -diacylphosphatidylcholines and phosphatidyl 
ethanolamines. This work showed T^ ,^ ATi^ and AH^ai to be dependent upon head 
group type, hydrocarbon chain length and degree of unsaturation. Further 
investigations concentrated upon transitions involving mixtures of diacyl lecithins of 
homogeneous chain length (99-101) heterogeneous chain length (102), and the 
addition of "foreign" molecules such as surfactants (103) and proteins (104) to 
membranes.
Addition of other lipids and foreign molecules to artificial membranes causes 
a widening of ATi^ and an alteration in T^, the degree of effect is highly dependent 
on the concentration and structure of molecules added to the membranes (103). 
Natural cell membranes produce far more complex transitions involving many lipid- 
lipid and lipid-protein interactions (104).
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3.1.3 DSC of Stratum Corneum
There have been several recent reports of thermal analyses of stratum 
comeum. Van Duzee (105) studied isolated human stratum comeum. He found 
four endothermie transitions with peak midpoints at 40, 75, 85 and 107°C. These 
results were later confirmed and substantiated by Golden et al (106), Goodman and 
Barry (107) and Knutson et al (52). However in these studies the presence of the 
lowest temperature transition (38-40°C) was variable.
The endothermie peaks can be assigned to thermal transitions of various 
parts of the stratum comeum. The highest temperature transition (107®C) is due to 
the thermal dénaturation of intracellular keratin. The transition at 85 ®C is lipid- 
associated and is thought to be connected with membrane protein-intercellular lipid 
complexes (108) although this suggestion has been debated (50,106). The transition 
at 75 °C has been assigned to the gel-liquid crystalline phase transition of the 
intercellular lipids. The lowest temperature broad transition at 40°C is also lipid 
associated being either a stmctural rearrangement or melting of sebaceous lipid 
(50).
Studies have also been carried out using the stratum comeum of other 
mammalian species. A pattem of transitions similar to human stratum comeum 
were found by investigators studying neonatal mouse tissue (109), hairless mouse 
tissue (52) and porcine stratum comeum (110) but with variations in the transition 
temperature.
Transdermal penetration enhancers have been shown to alter both the T^  ^and 
AHg^ of the lipid transitions of the stratum comeum (107,111). The extent of these 
effects was correlated to the potency of the chemicals as penetration enhancers 
which suggests their site of action is centred in the stratum comeum lipids (50,111).
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3.2 METHODS
3.2.1 Preparation of Liposomes
DSPC multilamellar liposomes were formed by an adaption of the method of 
Bangham (112). lOOptl of DSPC stock solution, usually l(X)mg ml \  in chloroform 
were pipetted into clean 1.5ml glass screwtop vials. The chloroform was blown off 
using a stream of dry nitrogen gas whilst the vial was rotated by hand. This 
produced a thin film of lipid on the inner surface of the vial. The vials were then 
placed under high vacuum overnight to remove any residual solvent. Phosphate 
buffered saline (PBS) pH 7.4 was added to the samples, usually 100/xl, and the vials 
sealed. The vials were then heated to 65®C, which is above the transition 
temperature of DSPC, for 30 minutes and whilst hot mixed on a bench vortex mixer 
for 30 seconds. The heating and vortexing procedure was then repeated as above.
The samples were then usually stored at 4®C overnight before thermal 
analysis. The liposomes were stable for at least 6  days at 4®C, no significant 
change in thermal characteristics were observed over that time period (Table 3.1).
3.2.2 Incorporation of Surfactant into the Liposomes
Two methods of preparing mixed lipid-surfactant vesicles were investigated. 
Either the phospholipid and surfactant were codeposited from chloroform to produce 
a mixed film in the vials prior to hydration, or the surfactant was added as a 
solution or suspension in buffer to a lipid film for hydration of the lipid.
There were no significant differences in the thermal behaviour between 
vesicles produced by either method (t-test, p>0.05) except in the case of the low 
HLB surfactant NP2 which was insoluble in water (Table 3.2). This was probably 
due to the difficulty in preparing homogeneous suspensions of the low HLB 
surfactants. For subsequent studies the codeposition method was adopted as 
standard.
For all experiments involving the Nikkol dodecyl ethoxylate surfactants the 
mass of surfactant added to the DSPC was calculated on a molar basis. This 
approach was used for some of the nonylphenyl experiments using a molecular
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Time of storage TmCC) AT.^(°C) AH „i
< 1 54.54±0.26 1.47 ±0.08 46.85 ±0.47
4 54.39±0.17 1.33 ±0.22 46.26±0.32
24 54.15 ±0.04 1.41 ±0.34 47.42 ±0.61
48 54.27±0.09 1.30±0.11 47.66±0.51
96 54.29±0.I8 1.28±0.26 46.16±0.31
144 54.14±0.10 1.18±0.06 45.98 ±0.17
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weight average. In other cases the surfactant present was calculated as a percent 
weight in final volume.
3.2.3 Thermal Analysis of Liposomes
For thermal analysis approximately lOmg of liposome or liposome/surfactant 
suspension was pipetted into preweighed DSC pans. The pans were hermetically 
sealed and reweighed.
3.2.4 Preparation of Stratum Comeum
Porcine skin from the back of the ear and human abdominal skin were 
obtained and stored as described (2.1). Both skin types were subjected to the same 
preparative methods for the isolation of stratum comeum.
Subcutaneous fat was removed by dissection with a #12 scalpel. The whole 
epidermis was seperated from the dermis by the method of Kligman and 
Christophers (113). Whole skin was immersed in distilled water at 60±1®C for 60 
seconds. The epidermis was then gently scraped and pealed from the dermis with 
the aid of a pair of curved forceps. The epidermis was then placed, stratum 
comeum up, on filter paper soaked in 0.05% trypsin solution in pH 7.4 PBS. This 
was sealed into a petri dish and incubated ovemight at 37°C. Following incubation 
the stratum comeum was washed by gentle vortex mixing three times in distilled 
water. The dermal side was gently bmshed with cotton buds to remove any 
adhering epidermal cells. The seperated stratum comeum was then dried on 
stainless steel racks under vacuum and subsequently stored desiccated over silica gel 
at -20®C until required.
3.2.5 Thermal Analysis of Stratum Comeum
Dry stratum comeum was cut into pieces of approximately 4mg and 
accurately weighed. Some samples were then washed for 20 seconds in hexane at 
0°C to remove surface lipids (105). The samples were allowed to rehydrate for 24 
hours at ambient temperature (18-20®C) over a saturated aqueous solution of
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CUSO4 , a relative humidity of 98% (114). This procedure was carried out in a 
glass desiccator fitted with an electric fan to circulate the humid air.
For samples treated with surfactant 0.4mg of surfactant was deposited onto 
the stratum comeum surface from 30^1 of absolute ethanol prior to rehydration. 
Control samples were prepared with 30/xl of ethanol only.
The hydrated stratum comeum was folded into preweighed aluminium DSC 
pans which were hermetically sealed and reweighed. From the stratum comeum 
weights before and after hydration the percentage hydration by mass was calculated. 
At least four sample controls were prepared for each treatment.
3.2.6 Extraction of Skin Lipids
Total stratum comeum lipids were extracted by a method adapted from Bligh 
and Dyer (115). Whole stratum comeum was prepared and stored as previously 
described (3.2.4). For lipid extraction the samples were weighed, cut into small 
pieces with dissecting scissors, and put in a clean glass 100ml beaker. The stratum 
comeum was then covered with extraction solvent (2 : 1  methanol:chloroform) 1 ml 
for every 25mg dry tissue, and homogenised for 3-4 minutes with a Ultra-Turrax 
homogeniser (Janke+Kunkel, Germany) at medium speed. The extraction was 
covered (Nescofilm) and allowed to stand at room temperature for 1 hour before 
rehomogenisation. The extract was filtered through Whatman #1 filter paper on a 
Buchner funnel under low vacuum. The beaker was rinsed with chloroform and the 
washings passed through the same filter paper. O.IM KCl was added to the filtrate 
to produce a two phase system. A solution of KCl was used rather than distilled 
water to force cholesterol sulphate into the organic phase (10). The extracts were 
then centrifuged at 3200 rpm for 15 minutes (MSE Chilspin) in clean glass 
centrifuge tubes. The upper aqueous phase was decanted and discarded and the 
lower organic layers pooled into a clean 100ml round botton flask. The chloroform 
was removed on a rotary evaporator below 40®C to leave a lipid film. This was 
taken up in a small volume of chloroform and transferred to a clean, dry
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preweighed glass vial. The chloroform was removed under a stream of dry nitrogen 
and finally high vacuum. The vial was reweighed and stoppered. The lipids were 
stored under nitrogen at -80°C until required.
3.2.7 Thermal Analysis of Extracted Skin Lipids
The hydration of extracted skin lipids and skin lipid/surfactant mixtures was 
carried out by one of the following two methods:
(1) The extracted skin lipids and lipid-surfactant mixtures were hydrated as 
for DSPC liposomes (see 3.2.1).
(2) About 5mg of lipids were deposited, or lipid-surfactant mixtures 
codeposited, from chloroform directly into preweighed DSC pans, the chloroform 
was removed under vacuum. The pans were weighed then rehydrated at 98% 
humidity (see 3.2.5) for 48hr. The pans were then hermetically sealed, reweighed 
and percentage water content calculated. At least two samples were produced for 
each treatment.
3.2.8 Calibration of the Dupont 910 DSC
The Dupont 910 DSC was calibrated with reference materials to produce 
accurate measurements of transition temperatures (temperature calibration) and for 
enthalpy calculations (cell constant calibration). The unit was calibrated prior to 
each set of experiments under the conditions of the experimental run, and 
recalibrated before any change in experimental conditions, heating rate, purge gas 
flow or sample pan type.
The cell constant was calculated from the melting transition of pure indium 
metal (iH® = 28.4 J g i). A two point temperature calibration was carried out 
with pure glass distilled water (T^  ^ = 0.0°C) and indium metal (Tm = 156.6°C).
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Table 3.3 Temperature ranges used for the various sample types analysed by DSC.
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3.2.9 Thermal Analysis Run Parameters
All samples were run on a Dupont 910 DSC attached to a Dupont 9900 
thermal analyser unit. The samples were run in hermetically sealed pans against an 
empty pan as reference. The DSC head was continually purged with dry nitrogen 
gas. Each sample was analysed at a heating rate of 5®C min-i over the temperature 
ranges detailed in Table 3.3.
3.2.10 Treatment of Data
The phase transition midpoint (T^) and transition enthapy O^cai) were 
obtained using the Dupont software. is expressed as kJ per mole of lipid for
the phospholipids and J per gram dry weight of extracted lipid and stratum 
comeum. The phase transition width (AT,^) was measured directly from the DSC 
traces. Figures quoted are mean±standard deviation (n=4) unless otherwise stated.
3.3 RESULTS
3.3.1 Accuracy and Reproducibility of Results
The T^  ^ value obtained for runs of the same sample was reproducible to 
<0.1°C . The intersample variation of a duplicate pair was slightly greater but 
generally reproducible to <0.2®C. AT,^ values were measured directly from hard 
copies of DSC traces. Errors due to measurement and line thickness were minimal 
(0.05°C). ATj^  values were normally reproducible to <0.2®C.
AHcai values were highly dependent upon both accurate sample weighing and 
baseline calculation. Variation in baseline placement resulted in estimates different 
by up to 15% of the endotherm, the differences being greater for wide, flat 
transitions. All samples were weighed on a four figure balance so that for a lOmg 
































3.3.2 Pure DSPC Liposomes
A typical heating curve for pure DSPC liposomes is shown in Figure 3.3. A 
sharp gel to liquid crystalline phase transition was observed with a of 
54.34±0.37°C (n=27), a AT.^ of 1.51±0.23“C (n=27) and a peak enthalpy 
^^cai) of 44.69±10.18 kJ mole-  ^ (n=27). From these values the cooperative unit 
(CU) was calculated to be 53 ±28 molecules. A smaller broad pretransition was 
noted at 51.51 ±0.24®C with of 4.3KJ mole-i.
3.3.3 Effect of Nonylphenyl Ether Ethoxylates
Addition of nonylphenyl ether ethoxylates to DSPC liposomes lowered T^, 
increased AT,^ and in some cases decreased AH^ i^ of the gel to liquid-crystalline 
phase transition. These effects were both structure and concentration dependent.
Figure 3.4 shows the effect of addition of increasing mole fraction NP6  
upon the DSPC gel to liquid-crystalline phase transition. At a concentration of 1.6 
mole% NP6  (0.1% ^/y) there was no significant change to the main transition 
peak, but the pretransition disappeared. Below this concentration this effect was not 
seen and the transition profile was as for pure DSPC. As the mole fraction of NP6  
increased the transition peak flattened and became broader up to 70 mole% NP6  
whereafter the transition became sharper. This is shown by a plot of AT,  ^ against 
mole fraction NP6  (Figure 3.5).
The T^ decreased linearly over the concentration range 0-70 mole% NP6  to 
a value of 41.81 °C (Figure 3.6). An increase of concentration to 83 mole % NP6  
caused T^  ^ to reduce to 34.93®C, further increases in NP6  concentration did not 
further reduce T^. There was no change in transition with addition of NP6  to 
DSPC liposomes.
Addition of NPIO to DSPC liposomes also caused reduction in T^ and an 
increase in ATi^ but the extent of the effects was lower than for NP6  and plateaued 

















Figure 3.4 The effect of increasing the mole percentage NP6  upon the DSC heating
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Figure 3.5 The effect of increasing mole percentage surfactant upon the value of 
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Figure 3.6 The effect of increasing mole percentage surfactant upon the value of 
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Figure 3.7 The effect of increasing mole percentage NPIO upon the value of AH^ai 
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Figure 3.8 values for the gel-liquid crystalline phase transition of DSPC/NPX 
mixed vesicles plotted as a function of surfactant ethoxy chain length. 1% (•), 5% 
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Figure 3.9 ATi^ values for the gel-liquid crystalline phase transition of DSPC/NPX 
mixed vesicles plotted as a function of surfactant ethoxy chain length. 1% (•), 5% 
(■) and 10% ( a )  ^ /y  surfactant. Mean±SD, n=4.
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concentration dependent reduction of apparent AH^ai which decreases from 44.69 kJ 
mole-1 for pure DSPC to 18.25 kJ mole-i DSPC at 54 mole% NPIO (Figure. 3.7). 
The effect of the series of nonylphenyl ether ethoxylates NP0-NP15 upon the 
of DSPC liposomes at concentrations of 1% and 10%(^/y) surfactant (constant 
DSPC concentration) is shown in Figure 3.8. At all three concentrations the lower 
ethoxy content members of the series were more potent at reducing T^. At the 
higher concentrations, 5  and 1 0 %, this relationship was much more pronounced. 
NP15 had little effect upon even at 10% whereas NP2 caused a 5.4°C reduction 
in at l% (^/y) and a 15.4°C reduction in at 10% concentration.
A similar trend was observed for the increase in ATi  ^ of the phase transition 
(Figure 3.9). Across the range the lower HLB surfactants produced far broader 
transitions than the more hydrophilic surfactants which had little effect on the phase 
transition. No significant trends were observed in the transition enthalpies.
3.3.4 Effect of Dodecyl Ether Ethoxylates
The lowering of the T^ of the gel-liquid-crystalline phase transition of 
DSPC liposomes with inclusion of increasing concentrations of C1 2 E3 , C 1 2 E5  and 
C1 2 E7  is shown in Figure 3.10. The 3 surfactants caused similar decreases in T^  ^up 
to concentration of 10 mole% surfactant. Above this concentration the curves 
diverged. The C1 2 E7  curve flattened off to a minimum T^ of about 47®C for 
concentrations of 40 mole% C1 2 E7  and above. A similar shaped curve was 
produced for C1 2 E5  when a constant T^ of about 42®C occurred for 50 mole% 
C1 2 E3  and above. For C1 2 E3  a constant T^ of about 34.5®C was reached with the 
addition of 6 6  Mole% surfactant and above.
Increases in AT,  ^ values for the phase transition with the incorporation of 
C1 2 E3 , C1 2 E5  and C1 2 E7  corresponded to decreases in T ,^ (Figure 3.11) except that 












6050 700 10 20 30 40 80
Mole % surfactant
Figure 3.10 The effect of increasing mole percentage surfactant upon the value of 
Tn, for the gel-liquid crystalline phase transition in DSPC/Ci2 En mixed vesicles. 
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Figure 3.11 The effect of increasing mole percentage surfactant upon the value of 
ATi^ for the gel-liquid crystalline phase transition in DSPC/Ci2 En mixed vesicles. 
C 1 2 E3  ( • ) ,  C1 2 E5  ( ■ ) ,  C1 2 E7  ( a ) .  Mean±SD, n=4.
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Figure 3.12 The effect of increasing mole percentage surfactant upon the value of 
the cooperative unit for the gel-liquid crystalline phase transition in DSPC/Ci2 En 
mixed vesicles. C1 2 E3  (#), C1 2 E5  (■), C1 2 E7  ( a ) .  Mean values.
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The cooperative unit of the phase transition was calculated for increasing 
concentrations of C1 2 E3 , C1 2 E5  and C1 2 E7  (Figure 3.12). Both C 1 2 E3  and C1 2 E5  
caused a rapid decrease in the size of the CU between 0 and 30 mole% surfactant 
when a minimum value was reached. Above this point further increases in 
concentration produced no charge in the CU. With C 1 2 E7  the size of the calculated 
CU was a complex function of surfactant concentration. A decrease was observed 
up to 20 mole% C1 2 E7  where a minimum was reached. Increases in concentration 
above this value caused an increase in size of the calculated size of the CU followed 
by a decrease above 50 mole% surfactant.
The DSC heating profiles of pure DSPC and DSPC/surfactant vesicles 
incorporating the surfactant range C 1 2 E0 -C 1 2 E8  ^ 1  50 mole% surfactant 
concentration, (1:1 molar ratio) are shown in Figure 3.13. Dodecyl alcohol, C1 2 EQ, 
removed the pretransition but had little effect upon the main transition. As the 
ethoxy content of the surfactant increased from C 1 2 E0 -C1 2 E3  there was an increase 
in the reduction of Tm and broadening of AT,^. As ethoxy chain length increased 
further, C^2 ^"(^i2 ^ '  this trend was reversed; the reduction in Tm and increase in 
AT,^ becoming smaller. T^ and AT,  ^values are presented graphically as a function 
of surfactant ethoxy chain length in Figures 3.14 and 3.15 respectively. Mixed 
micelles containing either C1 2 E5  or C 1 2 E6  showed biphasic melting transitions with 
two peak maxima (Figure 3.13). In Figure 3.14 the higher of the two T^  ^ values 
were plotted. Figures 3.14 and 3.15 also show the effect of the same surfactant 
series, C 1 2 E0 -C1 2 E8 , upon DSPC phase transition T^ and AT,  ^ at a 1:0.1 lipid to 
surfactant molar ratio (9 mole% surfactant). No relationship could be deduced 
between surfactant ethoxy chain length and transition enthalpy.
The size of the cooperative unit of the transition is shown as a function of 
surfactant ethoxy chain length in Figure 3.16 at 9 and 50 mole% surfactant. No 
clear relationship can be seen on 9 mole% surfactant but at 50 mole% the reduction 
in the size of the CU followed the same trend across the series as for the reduction 
















Figure 3.13 DSC heating curves of pure DSPC and DSPC/surfactant vesicles 
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Figure 3.14 values for the gel-liquid crystalline phase transition of DSPC/Ci2 En 
mixed vesicles plotted as a function of surfactant ethoxy chain length. 9 (■), and 50 
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Figure 3.15 AT,^ values for the gel-Hquid crystalline phase transition of 
DSPC/Ci2 En mixed vesicles plotted as a function of surfactant ethoxy chain length. 
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Figure 3.16 Size of the cooperative unit for the gel-liquid crystalline phase 
transition of DSPC/Ci2 En mixed vesicles plotted as a function of surfactant ethoxy 
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Figure 3.17 values for the gel-liquid crystalline phase transition of DSPC/CjoEn 
mixed vesicles plotted as a function of surfactant ethoxy chain length. 9 (■), and 50 
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Figure 3.18 AXi^ values for the gel-liquid crystalline phase transition of 
DSPC/CioEn mixed vesicles plotted as a function of surfactant ethoxy chain length. 
9 (■) and 50 (•) mole% surfactant. Mean±SD, n=4.
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3.3.5 Effect of Decyl Ether Ethoxylates
Figures 3.17 and 3.18 show the effect of incorporation of 9 and 50 mole% 
CioEg-CigEg upon the and AT,^ of the DSPC phase transition respectively. 
There was no significant difference between surfactants at 9 mole% surfactant. At 
50 moIe% C 1 0 E4  produced the greatest effect upon and ATi  ^ although the effect 
was not statistically different from the effects of C1 0 E3  (t-test, p<0.05).
3.3.6 Effect of Azone, Brij 30 and Brij 36T
The T^, ATi^  AHcai and calculated cooperative unit size of DSPC liposomes 
and mixed vescicles of DSPC with 9 and 50 mole% Azone and 50 mole% Brij 
series surfactants are given in Table 3.4.
3.3.7 Effect of Total Surfactant and DSPC Concentration
Table 3.5 gives the T^, AT,^ and AH<^ i values for 1:1 molar mixtures of 
DSPC with C1 2 E3  and C 1 2 E7  at concentrations of 0.126M and 0.0126M. No 
significant differences were observed in T^  ^ or AT,  ^ between the two concentrations 
for either surfactant (t-test, p<0.05). However for both C1 2 E3  and C1 2 E7  addition 
the AHç i^ value was lower at 0.0126M total surfactant.
3.3.8 The Influence of Surfactant Hydrophile-llpophile Balance (HLB)
The compiled data for the effects of 3 surfactant series, NP2-NP15, C1 2 E0 - 
Ci2 Eg, C1 0 E3 -C1 0 E5  and the Brij surfactants upon the DSPC T^ at 50 mole% 
surfactant is shown plotted as a function of surfactant ethoxy content (Figure 3.19) 
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Concentration DSPC + C 1 2 E3
Tn.(°C) AT,^CC) AH ^ i
0.126M 38.98+1.06 11.01+0.47 43.09±1.20
0.0126M 38.75 ±0.02 10.00±1.37 35.39±3.46
DSPC + C1 2 E7
TmCC) AT.^C’C) AH,.,
0.126M 45.76iO.69 2.54+0.24 47.24 ±2.01
0.0126 46.82±0.02 2.57±0.41 32.61 ±0.41
Table 3.5 The effect of surfactant/DSPC concentration upon the thermal 
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Figure 3.19 values for the gel-liquid crystalline phase transition for
DSPC/surfactant mixed vesicles plotted as a function of surfactant ethoxy chain 










2.0 3.8 5.6 7.4 9.2 11.0 12.8 14.6 16.4
Hydrophiie~Lipophiie Balance
Figure 3.20 values for the gel-liquid crystalline phase transition for
DSPC/surfactant mixed vesicles plotted as a function of calculated surfactant 
hydrophile-lipophile balance. NPX (■), Ci2 En (•), CjoEn (a). Mean±SD, n=4.
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3.3.9 Extracted Porcine Stratum Corneum Lipids
Solvent treatment of the stratum corneum (see 3,2.6) extracts the 
intercellular lipid. The solvent extracted material constituted 11.3±3.4% (n=5) by 
weight of the stratum corneum.
Hydration of the extracted lipids at 98% relative humidity, method 2 (see 
3.2.7), caused an average of 0.12±0.07mg (n = 10) of water per mg of dry lipid to 
be taken up by the sample.
Figure 3.21 shows a typical thermal transition profile for the heating of 
rehydrated porcine stratum corneum lipids. The lipids underwent a single broad 
transition with an average T^  ^ of 56.0±1.87°C, a AT,  ^ of 19.07+1.97°C and a 
AHçai of 29.36±4.89 J g"^  hydrated lipid. These values are means and standard 
deviations of duplicate samples from five preparations.
Lipids hydrated by the addition of PBS pH 7.4 to produce 10%(^/y) lipid 
mixtures produced similar shape transition profiles. No difference was observed in 
Tm for the two methods of hydration but the latter hydration with PBS produced 
lower AT.  ^ (13.45 + 1.33°C) and AH^ i^ (24.52+0.51) values.
3.3.10 Effect of Dodecyl Ether Ethoxylates on Extracted Stratum Corneum
Lipids
Individual lipid extractions showed some intersample variation in their 
thermal properties. Investigations of surfactant treatment, with a series of 
surfactants, were therefore carried out on a single batch of extracted lipid.
The addition of the dodecyl ether ethoxylates C1 2 E 1 -C1 2 E7  caused an 
increase in the percentage uptake of water upon hydration at 95 % relative humidity 
(Table 3.6) and a decrease in transition T^, Af,^ and AH^ i^ with respect to 
extracted lipid in the absence of surfactant. The thermal transition data (n=2) is 
presented graphically as a function of surfactant ethoxy chain length in Figures 
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^ 1 2 ^ 1 23.05 ±1.48
C1 2 E2 29.30±2.54
C1 2 E3 31.25+0.64
C1 2 H4 33.05+0.97
^12^5 28.25+0.07
^ 1 2 ^ 6 29.60+0.71
C 1 2 E7 29.25+1.76
 ^mg H2 0 /mg dry lipid, Mean ±  range, n=2
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Figure 3.22 values for the phase transition obtained with extracted porcine 
stratum comeum lipid/surfactant mixtures plotted as a function of surfactant ethoxy 
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Figure 3.23 ATi^  values for the phase transition obtained with extracted porcine 
stratum comeum lipid/surfactant mixtures plotted as a function of surfactant ethoxy 
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Figure 3.24 values for the phase transition obtained with extracted porcine
stratum comeum lipid/surfactant mixtures plotted as a function of surfactant ethoxy 
chain length for two lipid samples; A (•) and B (■). Mean±range, n=2
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Over the series C 1 2 E1 -C1 2 E7  reduced to a minimum with C 1 2 E3  
incorporation and then rose again as ethoxy chain length increased (Figure 3.22). 
The ATi  ^ and AH^ai values did not follow this pattern. As the ethoxy chain length 
of the surfactant increased both ATi  ^ (Figure 3.23) and AHç^i (Figure 3.24) 
decreased for the whole series studied.
3.3.11 Isolated Stratum Corneum
Rehydration of the desiccated stratum comeum at 98% relative humidity 
caused a mass increase of 26.58±9.9% (^/w) (n=25) which corresponds to 
0.26±0.1 mg of water being taken up per mg of dry tissue. Hexane washing had 
no effect on this rehydration.
Figure 3.25 shows a typical heating trace of hydrated human stratum 
comeum. Three endotherms were observed. upon primary heating centered at 
67.01±2.05®C, 78.41±3.5rC and 93.23±4.33°C (mean±SD, n=15). The 
corresponding AH^ai values were 1.17+0.34 J g -\ 0.558+0.15 J g'  ^ and 
1.29+0.40 J g-i respectively.
Upon reheat of the sample over the same temperature range the third 
transition disappeared and the first two peaks combined to form a single biphasic 
peak (e.g. Figure 3.25). The two peak maxima of this transition were 
62.74±1.44°C and 70.35 + 1.69°C. It was impossible to resolve the transition 
endotherms separately; the AHg i^ value overall was 2.33±0.96 g-^  dry tissue.
Porcine stratum comeum showed similar transition profiles, upon primary 
heating, to human tissue (Figure 3.26). However the T^ and AHg i^ values of the 
three peaks were different to human stratum comeum (Table 3.7). T^ was 5-10°C 
lower for the first and second peaks of porcine skin. The reheat of porcine stratum 
comeum produced a single endotherm with a Tj„ of 57.82±1.69®C and a AH^ai of 
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Figure 3.25 Typical heating curves for untreated, hydrated hum an stratum  

















20 40 50 8C
T emperczure (":)
1 0 0 1 2 0
Figure 3.26 Typical heating curves for untreated, hydrated porcine ear stratum 
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Species Peak TmCC) AH,„(J g-i)
Human I 67.01 ±2.05 1.17+0.34
2 78.41+3.51 0.558+0.15
3 98.23±4.33 1.29+0.40
Porcine 1 56.55±0.41 0.407+0.2
2 69.37+1.63 0.70+0.54
3 96.80±5.91 1.22+0.43
Table 3.7 Transition temperatures and enthalpies for the primary heating of human 
and porcine stratum comeum (mean±SD, n>  15).
Treatment Peak TmCC) Ah „ i(J g-')
Azone 1 64.59+0.09 0.494 ±0.08
2 77.98+1.81 0.326±0.02
3 98.83+2.6 1.203±0.32
C1 2 E3 1 64.83 +0.44 0.623 ±0.38
2 77.86+2.86 0.401 ±0.14
3 98.43+3.61 0.970±0.36
? 33.51+0.16 0.450±0.04
Table 3.8 The effect of Azone and C1 2 E3  upon thermal transitions in human 
stratum comeum (mean±SD n=4).
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3.3.12 Effect of Surfactants Isolated Stratum Corneum
Addition of Azone to human stratum comeum had little effect upon of 
the transition peaks but the first two peaks were flattened and had reduced AHp i^ 
values. C1 2 E3  also had this effect but it also produced a new peak centered at 
33.51 ±0.16®C (Figure 3.27 and Table 3.8). The third peak was unaltered in each 
case.
3.4 DISCUSSION
Pure DSPC liposomes exhibited a typical sharp, highly cooperative melting 
endotherm with thermodynamic parameters in good agreement with literature values 
(94,96).
The pretransition peak has been reported to be associated with a change in 
polar head group organisation and possibly a change in the angle of the lipid acyl 
chains from a tilted to vertical conformation (97). The pretransition is very 
sensitive to "foreign" molecules and very low quantities of drugs (116), surfactants 
(117) and other lipids (104) cause it to disappear. These observations were 
confirmed in this study; all surfactants investigated caused the disappearance of the 
pretransition even at low concentrations ( 1 . 6  mole%).
Addition of surfactant had pronounced effects on the DSPC gel to liquid 
crystalline phase transition. Incorporation of surfactant into the lipid bilayers 
decreased T^  ^ increased ATi  ^ and in some cases decreased These changes
are considered to reflect a decrease in the degree of crystallinity of the acyl chain 
packing and hence an increase in the fluidity of the lipid bilayers (97). Increase in 
ATi^  can be explained by decrease in cooperativity of the melt endotherm which 
results in enlargement of the temperature range within which both fluid and gel 
phases coexist in the lamellae (118).
These phenomena have been observed for many systems. Phillips, 
Ladbrooke and Chapman (101), working with molecular mixtures of 1,2- 
diacyllecithins of differing acyl chain length, showed that when the difference in
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hydrocarbon chain length of the two components was greater than or equal to four 
methylene groups, co-crystallisation of the mixtures does not occur and the lipids 
exhibit monotectic behaviour. The authors considered the decrease in T^ and 
increase in ATi^  to be due to the more disordered liquid hydrocarbon chains of the 
lower melting point component causing an increase in the kinetic motion of the 
ordered chains of the higher melting point component.
Nonylphenyl, dodecyl and decyl radicals are all at least six methylene groups 
shorter than the stearyl chains of DSPC, assuming that only the hydrophobic part of 
the surfactant is embedded in the bilayer. The introduction of short acyl chains into 
a bilayer is known to have a disruptive effect on membrane structure (119) 
decreasing Van der Waals forces between terminal methylene groups of the normal 
bilayer components, and lowering the T^ of the transition.
Another effect to be considered is the action of the ethoxy chains of the 
surfactants upon the choline head groups of the DSPC bilayers. Disruption of 
headgroup packing would cause a decrease in T^ and an increase in ATi .^ 
However, a reduction in repulsive forces between charged choline head groups due 
to surfactant interaction would have the opposite effect (118). The latter effect is 
more usually associated with anionic surfactants than nonionic surfactants.
The effect of nonionic surfactants upon lipid bilayers is dependent upon the 
molecular ratio of detergent to lipid (120,121). The following sequence of events 
has been suggested for addition of increasing amounts of nonionic surfactants to 
bilayers of pure phospholipid (73).
As surfactant concentration increases, with constant phosphipid content, 
surfactant is incorporated into the lipid bilayer and causes changes in its physical 
properties. When the bilayers are saturated with surfactant, mixed micelles begin to 
form resulting in a lamellar-micellar phase change and complete solubilisation of the 
membrane. This sequence of events presupposes that the surfactant used is 
hydrophilic enough to form micelles in an aqueous medium.
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The surfactant to lipid ratio at which mixed micelle formation and 
solubilisation occurs is dependent on both surfactant and target membrane structure. 
In most cases complete solubilisation begins at surfactant to lipid ratios between 0.8 
and 3.0 for good solubilising surfactants (121); those with an HLB between 12.5-
14.5 (73).
A typical nonionic surfactant in this HLB range and used in solubilisation 
studies is Triton X-100, (t-octylphenol decaether ethoxylate, OPIO). For Triton X- 
100/DSPC systems mixed micelle formation begins at a mole ratio surfactant to 
lipid of one (120). For the surfactants and concentration ranges studied in this 
investigation little solubilisation of the membrane was likely to occur and the 
phospholipid/surfactant mixtures were thought to remain mostly in the lamellar 
phase.
As the surfactant structure affected its activity each surfactant in a series 
exhibited a slightly different concentration/activity profile. NPIO reduced T„, and 
increased AT,^ indicating fluidisation of the bilayer (Figures 3.5 and 3.6). NPIO 
also caused a concentration dependent decrease in AH^ j^ (Figure 3.7). Similar 
behaviour was observed for the closely related surfactant Triton X-100 (OPIO) 
acting on DPPC membranes (117). These authors concluded that the surfactant 
was penetrating the bilayer and withdrawing a portion of the lipid from participating 
in the transaction.
The less hydrophilic nonylphenyl, NP6 , was a more potent membrane 
fluidiser, indicated by the greater reduction in T^ and greater increase in AT,  ^
(Figures 3.5 and 3.6). NP6  however, did not cause any significant effect on 
transition enthalpy. The ability of the surfactant to penetrate the membrane, its 
partitioning behaviour and the capacity of the membrane for the surfactant will all 
affect the surfactants concentration/activity profile. It is thought that less NPIO 
entered the membrane or was tolerated by the membrane than NP6  as the 
fluidisation effects plateaued at about 40-50 mole% for NPIO but continued to 
increase up to 80 mole% for 9N6 (Figure 3.5 and 3.6).
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For the whole nonylphenyl series these effects are reflected in the plots of 
and ATi^  of the DSPC phase transition as a function of average ethoxy chain 
length of the surfactant (Figures 3.8 and 3.9). As the number of ethylene oxide 
groups increased there was a decrease in the extent of the bilayer fluidisation. This 
was evident at l% (^/y) surfactant concentration but was greatly highlighted at the 
higher concentrations investigated, 5 and 10%(^/y). Little effect was observed 
with NP15 whereas, in contrast, NP2 and NPl were very potent membrane 
fluidisers.
These phenomena can be explained by the partitioning behaviour of the 
surfactants. For a given concentration of surfactant added to the liposomes, more 
of the low ethoxy content surfactant partitioned into the hydrophobic bilayer than 
the longer ethoxy chain molecules which were more soluble in the aqueous phase.
A point to be noted is that the concentration for the nonylphenyls was 
expressed in terms of percentage weight in volume. Therefore the numbers of 
molecules of low ethoxy content surfactants present were greater than for the longer 
ethoxy chain surfactants, due to the differences in average molecular weight. At 
10%(^/y) concentration approximately three times the number of NP2 molecules, 
with respect to NP15, molecules, would have been added to the system. There 
have been several other structure-activity studies upon the membrane perturbing 
effects of nonylphenyl ether ethoxylates.
The ability of the nonylphenyl ethoxylates to reduce the mobility of the 
protozoan Tetrahymena elliottiy presumed to be caused by the membrane activity of 
the surfactant, was found to decrease with increasing ethoxy chain length. (85). 
The maximum activity was seen with NP4 the lowest HLB surfactant studied in the 
series, despite its inability to micellize at ambient temperatures.
Similar findings were noted by Gadd and Curtis-Prior (8 6 ) who observed 
that spermicidal activity of the nonoxynols decreased with increasing hydrophilic 
chain length. Levin, (87) working with a large range of nonoxynols upon rat 
vaginal bioelectric activity found the most potent members of the series to be those
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with eight or nine ethoxy groups. The activity was reduced at both higher and lower 
ethoxy chain lengths. These observations were explained in terms of solubility. 
The more hydrophilic surfactants were too water soluble to attain an effective 
intermembrane concentration whilst the more hydrophobic surfactants were so 
poorly water soluble that access to be cell membrane was restricted. With the 
co-deposition of surfactant and lipid used in this study there was no such restriction 
of access to the membrane. Thus the more potent fluidisation potential of 
hydrophobic surfactants could be observed. However, it was possible during 
hydration for the surfactant to partition out to form a separate oily or micellar 
phase.
Although the nonylphenols studied formed a homologous series each 
surfactant was polymeric with respect to ethoxy chain length (see 2.4). Thus any 
structure-activity relationship observed would be expected to be compromised by 
the heterogeneity of the materials in use. The Nikkol dodecyl ether ethoxylates 
were all of single ethoxy chain length (see 2.4) so eliminating ambiguities due to 
varying polydispersity of the surfactants. Nevertheless, the results obtained with the 
series C 1 2 E0 -C1 2 E8  did show broad similarities to the results from the 
nonylphenols. In general, the pure surfactants produced sharper structure-activity 
effects, as might be expected.
The series C 1 2 E0 -C1 2 E8  caused comparible concentration dependent effects 
to the nonylphenyls with respect to HLB of the surfactants. The effect of C1 2 E7  on 
increases in membrane fluidity plateaued at a far lower concentration (20-40 
mole%) than C 1 2 E3  (50-60 mole%) (Figures 3.10-3.12), this was similar to the 
situation observed for NPIO and NP6  (Figures 3.5 and 3.6). C1 2 E5  showed
behaviour intermediate between C1 2 E3  and C 1 2 E7 .
If these effects were dependant upon partitioning behaviour it would be 
expected that the lower HLB surfactants would show greater effects at all 
concentrations. At low concentrations up to 20 mole% (Figures 3.10 and 3.11) 
differences in fluidisation were not greater than experimental error. This point is
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further illustrated in Figures 3.13 and 3.14. At 9 mole% surfactant no relationship 
between ethoxy chain length of the surfactant and membrane fluidising ability could 
be discerned, presumably too few molecules of any surfactant were present to have 
a distinctive effect upon the membrane.
At 50 mole% surfactant a far clearer relationship was seen. An optimum 
fluidisation effect was observed with C1 2 E3 , both higher and lower ethoxy chain 
lengths being less effective. This can be explained along the lines proposed by 
Levin (87) for the nonoxynols (see above), in terms of solubilities and partitioning 
behaviour.
Further observations of this type of phenomena were reported by Florence et 
al (63). This group studied several series of polymeric alkyl ether and ester 
ethoxylates, including the Brij 30 series (C1 2 E J. All the surfactants showed a 
parabolic relationship between membrane activity and lipophilicity. From this 
information the authors postulated that "the depth of penetration of the hydrocarbon 
chain may not be equal in a homologous series varying in ethylene oxide chain 
length, leading to variation in biological activity. When the number of ethoxy 
groups is lower than optimum, low concentration limits monomer activity, also part 
of the ethoxy chain may penetrate into the membrane. When the ethoxy chain 
length is above optimum, high molecular area and decreased surface activity will 
result in less efficient membrane penetration". From all these considerations it can 
be understood that C1 2 E3  has the right balance of partition coefficient, molar 
volume and the right depth of chain penetration to cause the greatest effect upon the 
DSPC membrane. During the current study it was observed that C1 2 E0 . 2  molecules, 
which were not able to micellize, had a tendency to separate as oily droplets, 
indicating poor membrane incorporation.
A comparison of the effects of all three series of surfactants investigated 
with respect to both ethoxy chain length and HLB is presented in Figures 3.19 and 
3.20. It can be seen that the lower HLB surfactants were the more potent membrane 
fluidisers, but the optimum ethoxy chain length and HLB was different for each
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hydrophobic moiety. Such effects have been noted for the haemolytic effects of 
several classes of nonionic surfactants of the same HLB (122). Below an optimum 
HLB both the decanol and dodecanol based surfactants showed a decrease in 
membrane fluidisation. Such an effect did not occur in the nonylphenol series 
where concentration was expressed as percent ^ /y . This can be explained by two 
factors; a higher molar concentration of the low HLB surfactants was present with 
respect to the larger molecules and low HLB surfactants (NPl and NP2) were 
polydisperse and therefore contained some higher ethoxylated molecules (2.4.4.1.1) 
which would have been more potent fluidisers.
The dodecyl ether ethoxylates were far more potent fluidisers of DSPC 
bilayers than the C^q equivalents. The potency of the 0 ^ 2  chain has been observed 
as the optimum chain length in studies upon several types of biological membrane 
(71,74,122,123). The reasons for this optimum potency have been debated. Schott 
(124) suggested the lauryl chain has the best balance between monomer 
concentration and penetratability of the membrane. Dominquez et al (125) 
postulated that the C1 2  chain can adopt a compact open cyclohexane structure that 
will allow the molecule to migrate deeper into the target membrane.
The industrial, polydisperse, counterparts of the Nikkol dodecyl ether 
ethoxylates are the Brij 30 surfactant series. Brij 30 (average C1 2 E4 ) showed far 
less activity than pure C1 2 E4  (Figure 3.19, Table 3.4). The sample of Brij 30 used 
had an average ethoxy chain length very close to that stated by the supplier (Table 
2.4). However, the presence of other chain length molecules, (see 2.4.4.1.2) most 
of which are less active would mean a lower concentration of C1 2 E4  present in the 
membrane. In addition longer chain micellar molecules present had the potential to 
solubilize shorter ethoxylates. Similarly, Brij 36T (C1 2 E1 0 ) appeared more active 
than would be predicted from the trends observed. The sample of Brij 36T used in 
this study had an average ethoxy chain length of 7.85+0.54, well below the 
expected value of E jq. As the surfactant contains many lower ethoxy chain length 
molecules its effectiveness as a fluidiser was increased.
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Azone is a well documented permeation enhancer (126) and is known to 
fluidise lipid membranes (50,127). In the study Azone proved to be a potent 
membrane fluidiser significantly reducing and increasing ATi  ^ (t-test, p < 0 .0 1 ). 
At 50 mole% concentration very similar effects to C1 2 E3  were observed on and 
AT,^ (Table 3.4). Azone has a C1 2  acyl chain and a low polarity headgroup thus its 
effects can be explained as surfactant properties. Azone probably has an effective 
HLB very similar to that of C1 2 E3 , and exerts similar effects on DSPC bilayers.
The storage of extracted stratum comeum lipids at 98% relative humidity 
resulted in 18.5+4.9%(^/\y) hydration. This was lower but not significantly 
different (t-test, p>0.05) from the percentage hydration of whole stratum comeum 
(26.58+9.9%^/\y) which would be expected to take up more water due to 
hydration of the keratin bundles in the comeocytes. Both preparations had been 
stored over dry slica gel and vacuum dried and, therefore, should have been fully 
desiccated. Addition of surfactant increased the extent of hydration of the extracted 
lipids. No similar observation was made for surfactant treated whole stratum 
comeum. The ethoxy chains of the surfactants may help bind extra water into the 
lipid preparations.
The extracted skin lipids are unlikely to form discrete liposomes using these 
methods of hydration. However, liposomes can be prepared by other techniques 
(128). It is more likely that in the hydrated state used in this study the lipids will be 
present as lamellae in the L-a-liquid crystalline phase (129). This hydration is 
unlikely to be complete when the method of incubation at 98% relative humidity 
was used. This was confirmed by the slightly lower T^  ^and AT,^ of lipids hydrated 
in excess PBS. T^ and AT,  ^ are known to decrease with hydration down to a 
minimum at the fully hydrated state (97). The T^  ^ of the melt of the extracted 
porcine lipids was in good agreement with results of previous studies on porcine 
skin (110). The AH^ai value for the transition was in good agreement with that 
obtained with extracted human stratum comeum lipids (129). As there was
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intersample variation, structure-activity studies with the surfactants were carried out 
on a single lipid extract.
Addition of surfactant caused a decrease in ATi  ^ and AH^ i^. This would 
seem to conflict with previous results with DSPC where a decrease in T^ was 
accompanied by an increase in AT,^, indicating membrane fluidisation. The ATi  ^
value of untreated lipid was very large, spanning the maximum expected for a 
biological transition (95). Addition of surfactant is unlikely to increase this and in 
high enough concentration may have increased the cooperativity of the transition. 
The inclusion of the surfactants, which have a lower melting point, does however 
reduce T^ and can be seen to be fluidising the lipids. C1 2 E3  induced the maximum 
decrease in Tm and can be thought of as the most potent fluidiser, in agreement 
with the DSPC studies.
The rehydration of dry whole stratum comeum at 98% relative humidity 
produced a large variation between samples. This has been observed by other 
investigators (79). The transition temperatures (T^) for the three transition peaks 
observed for the primary heating of whole human stratum comeum were lower than 
those previously reported. (105,106). The large degree of sample variation that 
occurs with different skin sources may account for this. The behaviour of the 
samples upon reheating agreed with the literature results (105,106).
The behaviour of porcine stratum comeum was similar to human upon 
thermal analysis but with lower T„^  values for the two lipid associated peaks (see 
3.1.3). This was in agreement with a previously described study (110). For both 
types of tissue the AH^^i value of the reheat peak was approximatey equal to the 
AHpai values of the two lipid associated peaks seen in the primary heating. This has 
been observed by other workers (107).
Goodman and Barry (107) found that addition of Azone removed the lipid 
assigned transitions. In this study the size of the transition was reduced but it was 
not completely removed. The difference may be explained by the different method 
used by Goodman and Barry who used Azone as an emulsion in 0.1% Tween 20,
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thus allowing some possible extraction of intercellular lipids. In this study Azone 
was deposited on to the stratum comeum from a volatile solvent, extraction of lipid 
components therefore being minimised.
Boustra et al (111) found Azone in propylene glycol reduced AH^ i^ of the 
transitions in stratum comeum and reduced the of the lipid peaks by about
15°C. In this study no significant decrease in was observed however both
Azone and C1 2 E3  reduced the AHgai of the lipid associated peaks. In a similar study 
to that of Boustra (111), Goodman and Barry (50) noted propylene glycol alone 
reduced by about 1 0 ®C so again the difference between studies may be due to 
the method of application of enhancer. Addition of C1 2 E3  to the stratum comeum 
produced a new peak at 33.51 ®C; the identity of this peak is unknown.
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CHAPTER 4
MEASUREMENT OF LIPID BILAYER FLUIDISATION 




4.1.1 Principles of Fluorescence Polarisation Spectroscopy (FPS)
The absorption of light by a molecule causes the electrons of that molecule 
to become excited and move to a higher electron orbital. The return of a paired 
electron to a lower energy state results in a fluorescent emission. Due to loss of 
energy in this process emission occurs at a longer wavelength relative to the 
absorption (130). Substances which display significant fluorescence, fluorophores, 
are generally those which possess delocalised electrons formally present in 
conjugated double bonds.
Upon excitation with polarised light the emission from fluorescent molecules 
is also polarised in the same plane as the excitation. If the fluorophore undergoes 
rotational motion during the fluorescent lifetime of the molecule, the time between 
absorption and subsequent emission of a photon, then depolarisation of the emission 
occurs. The degree of depolarisation, the anisotropy of the flurophore, is dependent 
upon the rate and extent of rotational diffusion of the molecule during the 
fluorescent lifetime. These motions of the molecule depend upon its size and shape 
and more so on the viscosity of the solvent. A change in solvent viscosity or in the 
viscosity of the microenvironment of the fluorophore will therefore result in a 
change in fluorescence anisotropy (131).
4.1.2 Measurement of Fluorescence Polarisation
The measurement of fluorescence polarisation or anisotropy is illustrated 
schematically in Figure 4.1. The sample is excited with vertically polarised light 
and the intensities of emissions are measured through polarisers orientated parallel 
to the plane of excitation i.e. vertically polarised (lyv) and perpendicular to the 
plane of excitation ie. horizontally polarised (Ivh)- From these measurements the 
polarisation anisotropy (r) can be defined as:-
ly y  - Ivh
r =   Equation 4.1
ly v  +  2 Ivh
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For completely polarised emissions which are observed with scattered light 
(1), Ivh -  0 and r = 1.0. For natural unpolarised light lyv = v^h and r = 0.
The lower the viscosity of the solvent the higher the rate of rotation of the 
fluorophore, hence the larger the depolarisation and the lower the value of r.
Equation 4.1 assumes that the excited and emitted light is not affected by 
any polarisation of the optical components. This is unlikely, as both excitation and 
emission monochromators are likely to partially polarise the incident light. 
Therefore a correction has to be added to the equation to account for this (3). This 
correction factor, as described by Azumi and McGlynn (133), is calculated from the 
ratio:-
^HV
0  = — Equation 4.2
H^H
i.e. horizontal excitation, emitted light measured in both vertical and horizontal 
planes. This leads to the corrected equation for anisotropy shown below.
l y y  -  G . I y H  
r = -----------  Equation 4.3
l y y  +  2 . G . I y y
4.1.3 Measurement of Fluorescence Polarisation in Membranes
Using FPS it is possible to obtain good estimations of membrane fluidity and 
the microviscosity of the membrane interior (134). The fluorescence anisotropy can 
be calculated from the polarisation characteristics of a hydrocarbon fluorescent 
probe embedded in the membrane. The anisotropy value will give an indication of 
the relative viscosity of the membrane interior and the microenvironment of the 
probe. This technique has been widely used in the study of membrane biophysics 
and biochemistry in both artificial model membranes (135,136) and naturally 
occurring cell membranes (137,138).
Below the gel-liquid crystalline phase transition of the membrane the motion 


































high anisotropy value will be obtained. It has been calculated that the maximum 
possible value of r that can be obtained for a probe in a membrane system is 0.4, 
any higher value than this must be due to light scattering (130).
If the membrane is heated, as temperature rises, the motion of the probe will 
gradually increase and concurrently r will decrease. At the phase transition the 
membrane fluidises, r will fall rapidly during the transition until reaching a 
constant, lower value in the liquid crystalline phase. This produces a sigmoidal 
curve for a plot of anisotropy (r) as a function of temperature over the phase 
transition range (139).
In this chapter the effect of the pure dodecyl ether ethoxylates C 1 2 E 1 -C1 2 E8  
upon the membrane fluidity of DSPC liposomes will be investigated by fluorescence 
polarisation measurements of some commonly used membrane probes.
4.2 METHODS
4.2.1 Preparation of Liposomes
DSPC multilamellar liposomes and DSPC/surfactant mixed vesicles were 
prepared as previously described (3.2.1, 3.2.2). Surfactant and DSPC were 
codeposited in all these studies. As this was a spectroscopic method a far lower 
concentration and far greater volume of liposome suspension was required than that 
used for DSC studies. For each sample 4ml of liposome suspension in pH 7.4 PBS 
was prepared in 4.5ml vials. In order to produce consistent size vesicles with a 
lower absorbance the dispersions were sonicated. A 3mm probe sonicator 
(Ultrasonics Ltd., Shipley, UK) was used at 50mw power for three minutes, 
without cooling, under helium, to produce smaller oligolamellar vesicles. The effect 
of liposome concentration and hence absorbance upon light scattering and associated 
depolarisation effects (140) was investigated over the DSPC concentration range 
0.025-1 mg ml'i using cis-pna as the fluorescence probe. Samples were prepared by 
serial dilution and analysed by methods described in 4.2.3 at 25°C. From the
1 1 1
results obtained (Figure 4.3.1.) it was decided to use a final DSPC concentration of 
0.05mg ml-i (6.34xlO-^M) for all experiments.
4.2.2 Addition of Fluorescent Probes
The DSPC liposome and DSPC/surfactant vesicle suspensions were purged 
with helium to prevent oxidation of the probe molecules. The fluorescent probes, 
cis-pna, DPH, ANS and perylene (see 2.6) were added in 1/d of solvent, as detailed 
in Table 4.1, to experimental samples which had been heated to 65®C. The probes 
were dispersed by vortex mixing for 2-3 seconds. The hydrophobic probes rapidly 
partitioned into the vesicles which were above their phase transition temperature. 
Any probe which remains in the aqueous buffer shows negligible fluorescence with 
respect to the incorporated probe (141,142). Final probe concentrations and probe 
to DSPC ratios are given in Table 4.1. The probe:lipid ratio was kept low to avoid 
perturbation of the lipid packing by the probe. For experiments involving cis-pna 
2,6 di-t-butyl-4-methyl phenol (BHT) was added as an antioxidant in a 1:1 ratio 
with cis-pna molecules.
For all experiments light scattering blanks were prepared. These were 
produced by addition of l/il of solvent only, or, for cis-pna, l/il of BHT in ethanol 
to the liposome suspensions.
4.2.3 Analysis of Samples by FPS
Fluorescence polarisation measurements were performed using a Shimadzu 
RF540 spectrofluorimeter fitted with a Shimadzu P/N 204-03290 fluorescence 
polariser (Shimadzu Ltd., Japan). The temperature in the cuvettes was controlled by 
a Howe temperature control unit (VA Howe, London UK) and the cuvette 
continually stirred with a magnetic stirrer. The instrument settings, slit widths, 
excitation and emission wavelengths, employed for each type of probe are detailed 
in Table 4.2.
1 1 2
Probe Solvent Final Cone" (M) Probe: Lipid
Cis-pna Ethanol 2 . 2  X 10-7 1:300
DPH THF 5.07 X 10-7 1:500
Perylene Acetone 2.2 X 10-7 1:300
ANS Ethanol 5.07 X 10-7 1:500
Table 4.1 The solvents used for adding fluorescent probes, the final probe 
concentrations in the cuvette and the probe:lipid ratios used in the FPS experiments
Probe Wavelength





» Slit width 5nm 
 ^Slit width 20nm
Table 4.2 The instrument settings used with the four probes for FPS analysis.
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Fluorescence intensities both parallel and perpendicular to vertically and 
horizontally excited light were measured for both experimental samples and light 
scattering blanks. Polarisation measurements were made either at 30®C or 
monitored over the temperature range 20-65 °C with a heating rate not greater than 
1°C min.-i
4.2.4 Alignment of Polarisers
Accurate measurement of fluorescent anisotropies requires that the polarisers 
be precisely positioned in the vertical and horizontal orientations. A dilute 
suspension of glycogen in water (Img ml'i) was used to produce scattered light that 
is 100% polarised, r=1.0  (130). The excitation polariser was set to vertical and the 
angular alignment of the emission polariser adjusted so that a minimum intensity 
was observed. This was the horizontal position. The maximum intensity was the 
vertical position. Once these had been determined the horizontal and vertical 
positions for the excitation polarisers were determined in a similar fashion with the 
emission polariser set vertically.
4.2.5 Treatment of Results
The blank scattering readings were subtracted from the experimental values 
and the anisotropy function calculated from Equation 4.3. For samples examined 
over a temperature range, plots were constructed of anisotropy against temperature. 
A typical plot is shown in Figure 4.2. From tangents drawn to the baselines and 
transition slopes, transition onset temperature (TJ and transition widths (T^) were 
calculated as shown. Results given are means±SD. For measurements of T^ and 
T^, n=4 whilst for determinations of r at 30®C n > 6 .
114
rTemperature (°C)
Figure 4.2 Fluorescent probe anistropy r, for a molecule incorperated into DSPC 
liposomes plotted as a function of temperature. From plots such as these it is 




4.3.1 Effect of Sample Absorbance upon Polarisation
Figure 4.3 shows the observed anisotropies of cis-pna fluorescence in DSPC 
liposomes at 25®C plotted against the sample absorbance at 325nm. The observed 
anisotropy (r) remained constant at approximately 0.25 up to an absorbance of 
around 0.5 absorbance units. Above this absorbance a decrease in r was observed. 
This was consistent with the findings of Lentz et al (140) working with DPPC 
liposomes and DPH.
4.3.2 The Effect of Dodecyl Ether Ethoxylates upon DSPC Bilayer Fluidity
Measured by Cis-pna Anisotropy
Pure DSPC liposomes showed a sharp decrease in probe anisotropy from 
0.25 to 0.10 between 50.4 and 54.1°C corresponding to the large increase in 
fluidity at the gel-liquid crystalline melting transition. This gave values for T^ , of 
50.45±0.07°C and T^=3.67±0.6®C. Addition of surfactant to the liposomes 
caused a broadening of T^ and a decrease in T^ ,, Figure 4.4. The traces shown are 
for liposomes with 50 mole% surfactant.
Tç and T^ were determined for mixed vesicles of DSPC/Ci2 Ei-8 > containing 
9, 33 and 50 mole% surfactant, this corresponds to 1:0.1, 1:0.5 and 1:1 
lipid:surfactant ratios. T  ^ and T^ were plotted as a function of surfactant ethoxy 
chain length (Figures 4.5 and 4.6). At 9 mole% there was no significant change in 
Tg or T^ of the phase transition with any of the surfactants (t-test, p <0.05). At 33 
mole% surfactant a greater effect was seen upon both Tg and T^. The decrease in Tg 
and increase in T^, was greatest with the intermediate HLB surfactants C1 2 E3 - 
C1 2 E6 , the higher and lower HLB surfactants being less potent fluidisers. This was 
highlighted at 50 mole% surfactant. Tg decreased and T^ increased over the range 
C1 2 E1 -C1 2 E5 , the effect being maximal at C 1 2 E5  (Tg=35.7±1.4°C,
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Figure 4.3 Observed anisotropy of cis-pna in DSPC liposomes at 25°C plotted as a 
function of the sample absorbance at 325nm.
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rTemperature (°C)
Figure 4.4 Typical FPS heating curves of pure DSPC and DSPC/surfactant vesicles 
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Figure 4.5 values, using cis-pna as the probe, for the gel-liquid crystalline phase 
transition of DSPC/Ci2 En mixed vesicles plotted as a function of surfactant ethoxy 
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Figure 4.6 values, using cis-pna as the probe, for the gel-liquid crystalline 
phase transition of DSPC/Ci2 En mixed vesicles plotted as a function of surfactant 
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Figure 4.7 Cis-pna probe anistropy at 30°C in DSPC/Ci2 En mixed vesicles 
containing 50 moIe% surfactant plotted as a function of surfactant ethoxy chain 
length. Mean±SD, n=18.
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There was a statistically significant difference (Students' t-test, P<0.05) 
between the values of and for C 1 2 E4 . 5  and the other surfactant treated 
vesicles.
Figure 4.7 shows cis-pna anisotropy, r, at 30°C plotted as a function of 
ethoxy chain length of the incorporated surfactant for DSPC liposomes containing 
50 mole% surfactant.
Pure DSPC liposomes gave an r value at 30®C of 0.249±0.005 (n=18). 
There was no significant difference in anisotropy between surfactants but C1 2 E4  and 
C1 2 E5  showed a significant decrease in r, with respect to pure DSPC liposomes.
4.3.3 The Effect of Dodecyl Ether Ethoxylates upon DSPC Bilayer Fluidity 
Measured by DPH Anisotropy
DSPC liposomes showed a sharp phase transition with a T  ^of 50.5±1.19°C 
and a T^ of 3.95±1.27®C when measured by DPH anisotropy. Addition of 
surfactant again produced a reduction in Tg and an increase in T^. Plots of Tg and 
T^ determined by DPH anisotropy, against the ethoxy chain length of incorporated 
surfactant are shown in Figures 4.8 and 4.9. Looking across the series C 1 2 E1 - 
C 1 2 E3  Tg decreased and T^ increased from C 1 2 E 1 -C1 2 E4 . The maximum effect was 
observed with C 1 2 E3  and C1 2 E4 . From Ci2 E4 -Ci2 Eg the trend was reversed, Tg 
increased and T^ decreased.
At 30°C in pure liposomes, DPH anisotropy had a value of 0.254±0.(X)7 
(n=9). Addition of surfactant reduced the value of r. The change in r with ethoxy 
chain length of surfactant displayed similar patterns to those obtained for the plots 
of Tg against ethoxy chain length (Figure 4.10). A minimum value was obtained 
with liposomes containing C1 2 E4 . The r value of DPH in liposomes containing 
C1 2 E 1 -C1 2 E3  was higher than for DPH in liposomes containing Ci2 E4 -Ci2 Eg.
The effect of the addition of increasing concentrations of C 1 2 E4  to DSPC 
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Figure 4.8 values, using DPH as the probe, for the gel-liquid crystalline phase 
transition of DSPC/C1 2 E1Î mixed vesicles containing 50 mole% surfactant plotted as 
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Figure 4.9 values, using DPH as the probe, for the gel-liquid crystalline phase 
transition of DSPC/Ci2 En mixed vesicles containing 50 mole% surfactant plotted as 
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Figure 4.10 DPH probe anistropy at 30°C in DSPC/Ci2 En mixed vesicles 
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Figure 4.11 The effect of increasing mole percentage C1 2 E4  upon the value of DPH 
probe anistropy at 30°C in DSPC/C1 2 E4  mixed vesicles. Mean±SD, n = 6 .
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observed up to 20 mole% C 1 2 E4 . Increasing the surfactant concentration beyond 
this caused a linear decrease in r with surfactant concentration.
4.3.4 The Effect of Dodecyl Ether Ethoxylates Upon DSPC Bilayer Fluidity 
Measured by Perylene Anisotropy
The probe anisotropy of perylene in DSPC liposomes was far lower than for 
either DPH or cis-pna. At 20®C, an r value of about 0.11 was obtained. As 
temperature increased r dropped linearly to about 0.05 at 50®C. Between 50-55®C 
r fell to a value of approximately 0.01 and remained constant up to 65®C. This 
produced a flat sigmoidal curve of r against temperature, Figure 4.12. From this 
curve Tg was calculated to be 50.87±0.17®C and T^ 3.32±0.106®C.
Tg and T^ were calculated for liposomes incorporating 50 mole% surfactant. 
When plotted as a function of surfactant ethoxy chain length, Tg was seen to be 
lowered most by surfactants in the range C 1 2 E2 -C1 2 E5 , C1 2 E 1 and C1 2 E6 -C1 2 E8  
were less potent (Figure 4.13). T^ was raised the most by C1 2 E5 . The other 
surfactants all had a similar less potent effect (Figure 4.14).
At 30®C the measured probe anisotropy of perylene in pure DSPC liposomes 
was 0.109±0.(X)7. Addition of surfactant caused a decrease in r. Figure 4.15. As 
a function of added surfactant ethoxy chain length there was no significant 
difference between the effects of C 1 2 E3 -C1 2 E8 , all of which lowered r to a value of 
about 0.06 (t-test, p<0.05 in all cases). This was significantly different to the 
value obtained in pure DSPC (t-test, p> 0.05). C1 2 E1 and C1 2 E2  had less of an 
effect upon r at 30®C.
The effect of the addition of increasing concentrations of C1 2 E4  to DSPC 
liposomes upon perylene anisotropy is shown in Figure 4.16. No effect was 
observed upon r up to 9 mole% surfactant, above which increasing surfactant 
concentration caused a linear decrease in r.
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rTemperature (°C)
Figure 4.12 Probe anistropy r, plotted against temperature for perylene 
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Figure 4.13 values, using perylene as the probe, for Jhe gel-liquid crystalline 
phase transition of DSPC/Ci2 En mixed vesicles containing 50 mole% surfactant 
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Figure 4.14 values, using perylene as the probe, for the gel-liquid crystalline 
phase transition of DSPC/Ci2 En mixed vesicles containing 50 mole% surfactant 
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Figure 4.15 Perylene probe anistropy at 30®C in DSPC/Ci2 En mixed vesicles 
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Figure 4.16 The effect of increasing mole percentage C1 2 E4  upon the value of 
perylene probe anistropy at 30°C in DSPC/C1 2 E4  mixed vesicles. Mean±SD, n = 6 .
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4.3.5 The Effect of Dodecyl Ether Ethoxylates upon DSPC Bilayer Fluidity as
measured by ANS Anisotropy
The probe polarisation anisotropy of ANS was measured only at 30°C. In 
pure DSPC liposomes a value of 0.159+0.006 was obtained. Addition of C1 2 E 1 - 
C1 2 E3  to the liposomes caused no significant change in r (Figure 4.17). However, 
over the range C1 2 E4 -C1 2 E5  there was a continual decrease in r, a minimum being 
reached with Further increases in ethoxy chain length of the surfactant
produced higher values of r. C1 2 E4 -C1 2 E7  all produced a statistically significant 
decrease in r with respect to pure DSPC liposomes (t-test, p>0.05).
4.3.6 The Effect of Azone on DSPC Bilayer Fluidity Measured by FPS
Table 4.3 shows the calculated T  ^ and T^ of the gel-liquid crystalline phase 
transition of DSPC liposomes containing 9, 33 and 50 mole% Azone by cis-pna 
FPS and 50 mole% Azone using DPH and perylene as probes. The table also 
shows the probe anisotropy, r, of the above stated systems and ANS anisotropy in 
DSPC liposomes containing 50 mole% Azone. At 9 mole% Azone no significant 
effect was observed. With 33 mole% Azone with cis-pna and 50 mole% Azone 
with all four probes Tg decreased and T^ increased. In the same systems, r at 30®C 
showed a significant decrease with respect to pure DSPC liposomes (t-test,
p > 0 .0 1 ).
4.4 DISCUSSION
The transition onset temperatures and transition widths of the gel-liquid 
crystalline phase transition of DSPC liposomes obtained with three probes cis-pna, 
DPH and perylene were all in close agreement with each other and reported 
literature values for both FPS (136,143) and other techniques (96). The transition 




0.180 -  
0.160
Œ 0.140 +  
o
L_
O  0.120 — en
■H
Œ  0.100 +
0.080 -  
0.060
0.0 1.0 2.0 3.0 4.0 5.0 6.0 7.0 8.0 9.0
Number of ethoxy groups
Figure 4.17 ANS probe anistropy at 30®C in DSPC/Ci2 En mixed vesicles 
containing 50 mole% surfactant plotted as a function of surfactant ethoxy chain 
length. Mean±SD, n=9.
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Probe Tg C O Tw C Q r @30°
Cis-pna » 49.1 ±0.14 4.52+0.03 0.252 +0.013
b 43.3+2.03 7.00+1.20 0.232+0.005
c 39.9+2.50 8.80+1.50 0.226+0.013
DPH c 38.2+1.06 13.62+1.9 0.156+0.017
Perylene ^ 42.6+0.07 7.63 + 1.10 0.042 +0.005
ANS - - 0.123+0.002
Table 4.3. The effect of Azone on the Tg and T^ of DSPC liposomes and probe
anisotropy, r, at 30°C measured by FPS with four fluorescent probes
 ^9 mole% Azone
 ^33 mole% Azone
 ^50 mole% Azone
Tg and T^ (mean±SD, n=4)
r (mean±SD, n > 6 )
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transitions measured by DSC (Chapter 3). The T^ values were calculated as the 
entire transition width incorporating the pretransition, whereas AT,^ values were 
calculated as the peak width at half peak height. The r values obtained in gel and 
fluid phases of pure DSPC for cis-pna, DPH and perylene were in agreement with 
literature values (140,143).
The incorporation of dodecyl ether ethoxylate surfactants into the lipid 
bilayers reduced the phase transition temperature and increased the phase transition 
width. The changes in these parameters are indicative of disruption of the ordered 
packing of the lipid chains causing increased fluidity in the lipid bilayers and a 
reduction in the cooperativity of the melt (see discussion in Chapter 3).
Incorporation of surfactant also caused a reduction in the probe anisotropy 
(r). A mixture of long (C^g) and short (C1 2 ) acyl chains does not pack in as tight a 
crystalline structure as pure lipid (119). The extent and strength of molecular 
interactions between lipid molecules and probe molecules would therefore be 
reduced in the surfactant treated systems. This allows the probes to undergo a 
greater amount of molecular rotation and translational motion thus reducing r with 
respect to its value in pure DSPC bilayers.
The relationship between the extent of bilayer fluidisation and surfactant 
structure could be expected to be equivalent in the presence of all four fluorescent 
probes used. However, the results indicated that this fluidisation caused different 
effects on the rotational motion of each probe.
The observed differences in the surfactant structure/bilayer fluidisation 
relationship between probes was thought to be dependent upon probe structure, 
probe location in the membrane and probe/lipid/surfactant interactions.
Due to their differences in structure each probe will occupy a different 
location and orientation in the bilayer. Cis-pna is C^g fatty acid and was expected 
to sit in the same plane of the membrane as the C^g chains of the DSPC molecules 
(141,144). DPH and perylene are both highly hydrophobic molecules and are used 
to probe the nonpolar membrane interior (136,145,146). ANS, however, has a
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negatively charged sulphonate group attached to a hydrophobic naphthalene group. 
These two groups give the molecule an amphipathic nature so ANS is thought to 
adsorb at the bilayer polar/non polar interface and is regarded as a good probe for 
studying the headgroup vicinity of the membrane (145,147). This has been 
confirmed by X-ray diffraction studies of phospholipid membranes containing ANS 
(148). This information is summarised diagrammatically in Figure 4.18
When cis-pna was used as the probe, C 1 2 E4  and C1 2 E5  showed the greatest 
degree of membrane fluidisation observed by all three considered parameters, Tg, 
T^ and r at 30°C. As cis-pna is located in the membrane plane similarly to a DSPC 
acyl chain it would be expected to behave similarly to DSPC molecules in response 
to perturbing agents such as heat or surfactant addition. The results obtained with 
this probe would therefore be expected to be in good correlation with those obtained 
in the previous chapter by DSC, where C 1 2 E3  was the optimum membrane fluidiser. 
The differences observed may have been related to the differences in surfactant and 
DSPC concentrations. For both DSC and FPS studies 1:1 lipid/surfactant ratios 
were used but for FPS the overall concentration was 2000 times lower than for 
DSC. This may have affected phase and partitioning behaviour of the surfactants 
emphasising the importance of phase ratio in the partitioning of surfactants into 
membranes. These concentration differences would be expected to effect the results 
with all probes studied. The interaction of the surfactant ethoxy chains with the cis- 
pna carboxyl group is another factor which may have caused a difference between 
the DSC and FPS results. Although there were significant differences in Tg and T^ 
as a function of structure, there was less variation in probe anisotropy at 30®C 
within the series of surfactants, although C 1 2 E4  and C 1 2 E5  treated liposomes were 
significantly more fluid than pure DSPC systems. These results suggest that the 
fluidity of the lipids in the gel-crystalline phase at 30®C, physiological skin 
temperature, will be increased by the presence of the surfactants, but the degree of 






















Using DPH as the probe C1 2 E3  and C1 2 E4  were the most potent membrane 
fluidisers, indicated by the change in and T^. When assessed by probe 
anisotropy at 30°C, C 1 2 E4  was judged to be the most potent fluidiser. The effect of 
the surfactants measured with perylene showed a more complicated relationships 
between structure and fluidisation. This may be due to the difficulties in the precise 
measurement of T^ and T^ with the flatter transition profiles obtained with 
perylene.
DPH and perylene might be expected to give similar results as they both 
probe the same microenvironment; the bilayer interior. However, with perylene a 
wider range of surfactants (C1 2 E2 -C1 2 E5 ) was observed as effective fluidisers, when 
judged by T^ . and T^. Differences were also observed between the results obtained 
with perylene and DPH with respect to the concentration dependent change in 
anisotropy with added C 1 2 E4  to DSPC bilayers. Less C 1 2 E4  (9 mole%) was needed 
to invoke a decrease in the r value for perylene compared to the 2 0  mole% C 1 2 E4  
required to invoke such a change in DPH anisotropy.
These effects may be associated with differences in probe location although 
both were expected to reside in the membrane interior. Perylene is thought to 
locate within the bilayers between the terminal methylene groups of the DSPC 
(145). The disc shaped, planar, perylene molecules do not easily fit into ordered 
crystalline systems. An increase in acyl chain flexibility as the acyl chain is 
transcended from head group to terminal methyl has been reported (149) which 
creates a slightly more fluid region in the bilayer centre. The region may act as a 
solvent for perylene molecules. DPH on the other hand, can be envisaged as a long 
rod shaped molecule (150). It is thought to be more evenly dispersed throughout 
the bilayer interior, both in the bilayer centre and between the acyl chains of the 
DSPC (136). The anisotropy observed is a mean of the anisotropic movements of 
all probe molecules in the membrane regardless of their location. The molecules 
near the bilayer interface will be more constrained than those deeper in the bilayer
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interior. A fluidising compound may exert a graded effect upon fluidisation down 
the acyl chains into the bilayer.
In membranes containing two non-ideally mixing components, those with 
large differences in acyl chain length, lateral phase separation can occur (101). If 
the fluorescent probe molecule preferentially partitions into either a more fluid or 
more crystalline phase the measured anisotropy will be biased to that area of the 
membrane (139). Cis-pna and DPH have gel crystalline-liquid crystalline partition 
coefficients of 0.7+0.2 (142) and 1.2+0.2 (151) respectively and so will distribute 
fairly evenly between phases giving a good average viscosity. Perylene is thought 
to preferentially partition into more fluid phases (14,19) so may give lower than 
expected anisotropy values.
The effect of probe partitioning would have a greater effect on the total 
probe anisotropy (r) than on the determination of the phase transition parameters T  ^
and T^. This may explain why the plots for T  ^ and T^ differ from those for r at 
30®C, which was most notable with perylene. The values of r in liposomes 
containing C1 2 E7  and Ci2 Eg were much lower than expected (Figure 4.15) from the 
experiments of surfactant partitioning behaviour described earlier (3.4.). This could 
be explained by the probe becoming incorporated into surfactant micelles which 
may form with hydrophilic surfactants. Such micelles may produce a lower probe 
anisotropy than DSPC liposomes or DSPC/surfactant vesicles. Such effects were 
observed when r was measured for both DPH and perylene at 30°C in samples 
prepared without DSPC, i.e. surfactant only, (results not shown). The net effect 
observed would be a lower value of r, even though C1 2 E7  and Ci2 Eg may not alter 
the gel-liquid crystalline phase transition of DSPC.
When ANS was used as the probe the largest increase in membrane fluidity 
was obtained with the surfactant range C1 2 E4 -C1 2 E7  with maximum fluidisation 
observed with C 1 2 E5 . As with the other probes the very high and very low HLB 
surfactants had less effect.
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The interaction of surfactants with the DSPC bilayer at the polar interface 
observed with ANS will be dependent upon the surfactant penetration of the bilayer 
and the interaction of the surfactant ethoxy chain with the polar head region of the 
DSPC and ANS probe. In phosphatidylcholine membranes the ANS binding site 
appears to be composed of four polar choline headgroups (147). Changes in the 
character of these sites due to perturbation by foreign molecules will result in 
reduced or altered binding of the ANS (147). The surfactant ethylene oxide chains 
may disrupt headgroup packing or the hydration sphere that would be bound around 
the polar groups. Surfactants in the range C 1 2 E4 -C1 2 E 7  may have the most 
appropriate balance of partition coefficient and a long enough ethoxy chain length to 
cause disruption of the headgroup region.
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CHAPTER 5
MEASUREMENT OF LIPID BILAYER FLUIDISATION 
BY ELECTRON SPIN RESONANCE SPECTROSCOPY
141
5.1 INTRODUCTION
5.1.1 Principles of Electron Spin Resonance Spectroscopy
Electron spin resonance spectroscopy (ESR) can be described as the study of 
molecules containing unpaired electrons by observing the magnetic field at which 
they come into resonance with monochromatic radiation (152).
The layout of a basic spectrometer is shown schematically in Figure 5.1. It 
consists of a microwave source (a Klystron), the sample cavity, a microwave 
detector and an electromagnet that produces fields that can be varied in the region of 
0.3 Tesla (3 KGauss). Magnetic fields of about 0.3T correspond to produce 
resonance with an electromagnetic field of frequency of 9GHz and wavelength 3cm.
An ESR spectrum is obtained by monitoring the microwave absorption by a 
molecule as the magnetic field strength is changed. As only molecules that possess 
unpaired electrons will show spin resonance the technique is used to study free 
radicals or triplet states formed during reactions. ESR can also be used to study 
systems that do not possess suitable molecules by incorporation of stable radicals 
into these systems as probe molecules.
The most important feature of ESR spectra is their hyperfine structure, the 
splitting of individual resonance lines. The extent of hyperfine splitting observed 
for a particular molecule is determined primarily by the spin of the molecules 
nucleus. If the molecule has a nuclear spin of ‘/ 2  two spin orientations are possible 
and two resonance positions will occur. The absorption spectrum will be split into 
two lines. The field separation between the two lines is known as the hyperfine 
splitting tensor which is termed A.
If the radical is based around a nitrogen atom, for example a nitroxide 
group, the ESR spectrum will be split into 3 lines of equal intensity as the i^N 
nucleus has 3 possible spin orientations +1, 0 and -1. The hyperfine splitting 
tensors for a nitroxide radical are affected by the fact that the interactions with the 
applied magnetic field are anisotropic due to the axial symmetry of the x orbital 
electrons in the nitroxide radical. This is very relevant when the motion of the
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Figure 5.1 The basic layout of a typical electron spin resonance spectrometer.
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probe is restricted in viscous solvents. Two characteristic hyperfine splittings can 
be determined from the ESR spectra. These are termed and A _ l  which are the 
hyperfine splitting generated when the magnetic field is parallel and perpendicular 
to the TT orbital axis of the nitroxide bond respectively (153).
The viscosity of the medium surrounding the probe has an effect upon 
spectra. In a sample that contains probe molecules in all possible orientations in the 
absence of molecular motion, for example in a dispersion of crystalline powder, a 
complicated spectrum is produced (153). The contribution of all molecular 
orientations is added and the observed spectrum is of the type shown in Figure 5.2. 
This is known as a 'powder spectrum'. The distance between the low and high field 
peaks is a direct measure of 2Au (154,155).
If the nitroxide radical is tumbling in solution all orientations are present but 
the resonance position will hop from one position to another as the molecule 
changes orientation in the magnetic field. This resonance exchange process leads to 
averaging of the hyperfine splitting tensors and intermediate values are obtained. 
The value of A^ will decrease and A_l increase. As the rate of molecular tumbling 
increases the extent of the averaging will also increase. A typical ESR spectrum for 
a nitroxide radical present on a fatty acid chain (see 5.1.3) undergoing fast 
anisotropic motion in a comparatively fluid membrane is shown in Figure 5.3. Both 
An and Aj_ can be measured directly from the spectrum.
5.1.2 The Order Parameter: A Measure of Probe Anisotropic Motion
As described previously, an increase in probe motion results in a decrease in 
An and an increase in A_l. Therefore the quantity Ajj-Aj. reflects the degree of 
order of the spin label. This is often normalised relative to the maximum possible 
splitting measured from powder spectra of single crystals, to give a dimensionless 
quantity, the Order Parameter, S, where:
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Figure 5.3 Typical ESR spectrum for a fatty acid nitroxide spin probe undergoing 
fast anisotropic motion in a fluid membrane.
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Aji - A_l
S =  --------------------- Equation 5.1
A^-(^A)(A^+Ayy)
Where A^ ,^ A ^  and Ayy are the principle hyperfine splitting tensors corresponding 
to the molecular axes of the spin label. For nitroxides attached to the acyl chain of 
fatty acids (5.1.3) the Z axis is parallel to the long axis of the probe, is the 
limiting value of An and (^A)(A^+Ayy) is the limiting value of Aj_.
The hyperfine splittings have been shown to depend on the polarity of the 
environment so a polarity normalisation term, a^Vag, is introduced to Equation 5.1 
to give the order parameter described by Hubbell and McConnell (155).
An~A_L
S = ---------------------- . l ^ \  Equation 5.2
Azz-e^)(A»+Ayy) [j; )
where a^’ = (1/3) A^^+A^+Ayy and a  ^ = (1/3)Ah+2A_l.
The principle hyperfine splitting values required to calculate the order 
parameters have been previously determined for the fatty acid probe used in this 
study (5-doxyl-stearic acid) to be 32.9, 5.9 and 5.4 gauss for A^, A ^  and Ayy 
respectively (156). The relevant order parameter can thus be reduced to:
S = 0.5407. (Aij-Aj_)/ao Equation 5.3
5.1.3 Anisotropic Motions of Nitroxide Probes in Membranes
A wide variety of nitroxide probes have been used in membrane studies. 
These range from simple molecules incorporating nitroxides such as TEMPO (157) 
to spin labelled fatty acids (154-156), phosphatidylcholines (149) and nitroxide 
labelled steroids (158,159). These more complicated molecules all contain the 2,2- 
dimethyl-N-oxyl-oxazolidine moeity which is normally abbreviated to 'doxyT. The 
chemical structures of some of these probes are shown in Figure 5.4.
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Fatty acid nitroxide probes have been used by many investigators to study 
membrane fluidity and structure (156,158-160). The fatty acids are assumed to sit 
in the bilayer with the changed carbonyl group anchored at the membrane surface. 
The position of the doxyl group on the acyl chain can be varied so different depths 
into the membrane can be probed. Using this approach it has been shown that the 
lipid acyl chains have a greater freedom of movement as the distance from the 
membrane surface increases, i.e. membranes are more fluid in their central core 
compared to just below the charged head groups (141,156).
5.1.4 Aim of the Investigation
In this study the nitroxide fatty acid probe 5-doxyl stearic acid (5-DS) Figure 
5.4, will be used to evaluate the effect of the surfactants C1 2 E1 -C1 2 E8  upon the 
membrane fluidity of DSPC liposomes. The same molecule will be used to probe 
the intercellular lipid bilayers of porcine stratum comeum in-situ to determine any 
effects the surfactants have upon the stratum comeum intercellular lipid fluidity.
5.2 METHODS
5.2.1 Preparation of DSPC Liposomes
For the ESR studies DSPC liposomes were prepared by an adaption of the 
method described previously (3.2.1). For ESR the final concentration of DSPC 
used was 0.08M (0.126M was used for the DSC studies). The nitroxide probe 5- 
DS was deposited into the glass vial from ethanol after the DSPC and surfactant had 
been deposited from chloroform. The amount of 5-DS added was kept to a 
minimum to avoid perturbation of the membrane by the probe. The 5-DS was used 
at a final concentration of 2.67xlO-'^M, that is a molar ratio of DSPC:5-DS of 
300:1.
For the ESR studies borate buffer pH 8.8 (2.2.3) was used rather than PBS 
pH 7.4 which was used in the DSC and EPS studies. A higher pH was chosen to 
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Figure 5.4 Typical nitroxide spin probes used in membrane investigations.
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ionised mixtures of 5-DS in membranes it has been reported that the spectral trace 
can be complicated by two components of the spectrum which are suggested to 
relate to the -COO" and -COOH forms of the carboxyl group (158).
For analysis by ESR approximately 50^1 of the 5-DS labelled liposomes 
were injected into 1 mm bore quartz capillary tubes which had been sealed at one 
end with a flame.
5.2.2 Preparation of Stratum Corneum
Porcine ear stratum comeum was prepared and stored as described 
previously (3.2.4). For ESR spectroscopy pieces of stratum comeum of 
approximately 2 .5 cm^ were cut and allowed to rehydrate at a relative humidity of 
98% (see 3.2.5) for 24 hours. IxlQ-^ moles of 5-DS was then deposited onto the 
stratum comeum surface from 20/xl of absolute ethanol. For surfactant treated 
samples 2 .2 x 1 0 ^ moles of surfactant was deposited onto the stratum comeum 
surface from 20/xl of acetone at the same time that the 5-DS was applied. The 
solvents were evaporated using a stream of dry nitrogen to leave a thin film of 5-DS 
and surfactant. For control samples 20^1 of acetone only was applied to the skin. 
The surfactant and 5-DS were left for 24 hours at room temperature to penetrate 
into the skin. Excess surfactant and probe were then washed from the stratum 
comeum surface by immersing the sample in acetone at 0°C for 5 seconds and 
blotting dry on tissue. The samples were then carefully folded, rolled and placed 
into 2 mm intemal diameter quartz capillary tubes which had been sealed previously 
at one end in a flame.
5.2.3 Collection of ESR Spectra
All ESR spectra were collected using a Varian E3 spectrometer (Walton-on- 
Thames, UK). Normally samples were scanned over a 200 Gauss range centred at 
3270 Gauss. The microwave frequency and power were approximately 9.18 GHz 
and 20mw respectively. All samples were analysed at 30±0.5°C. The temperature
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in the cavity was controlled with a nitrogen-flow temperature regulation system the 
performance of which was monitored with a nickel/chromium-nickel/aluminium 
thermocouple attached to a digital display unit (RS Components, Corby, UK). All 
spectra were collected in duplicate.
5.2.4 Analysis of Spectra
The hyperfine splittings Ajj and Aj_ were measured directly from the ESR 
spectra obtained, as shown in Figure 5.2, allowing calculation of the order 
parameter, S, according to Equation 5.3.
RESULTS
5.3.1 Pure DSPC Liposomes
Figure 5.5 shows a typical ESR spectrum for 5-DS incorporated into DSPC 
liposomes at 30°C. The small bar represents a distance equal to 10 Gauss. The 
hyperfine splittings taken from spectra of replicate samples were 29.59±1.18 and 
9.35 ±0.54 for An and A_l respectively. The calculated value of S for the DSPC 
liposomes was 0.679±0.026 (mean±SD, n=21).
Figure 5.6 shows that ESR spectra for 5-DS in DSPC liposomes with the 
incorporation of 50 mole% of dodecyl ether ethoxylates C1 2 E1 -C1 2 E8 . Addition of 
surfactant caused the spectra lines to narrow and become more pronounced. The 
presence of surfactant also altered the hyperfine splittings. A^ decreased and Aj_ 
increased relative to the values obtained in pure DSPC liposomes. Both these 
changes in splitting tensors reduced the order parameter, S.
The values of S plotted against the ethoxy chain length of the dodecyl ether 
ethoxylate added to DSPC liposomes at 9, 33 and 50 mole% surfactant are shown in 
Figures 5.7, 5.8 and 5.9 respectively. At 9 mole% surfactant the addition of 
C 1 2 E1 -C1 2 E3  caused no significant change in the value of S with respect to its value 
in pure DSPC liposomes (t-test, p <0.05). Incorporation of C1 2 E4 -C1 2 E8  resulted 
in a decrease in S to approximately 0.55. C 1 2 E7  caused the greatest reduction in S
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Figure 5.5 ESR spectrum for 5-DS incorporated into pure DSPC liposomes at 
30°C.
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Figure 5.6 ESR spectra for 5-DS incorporated into DSPC/Ci2 En mixed vesicles 
containing 50 mole% surfactant at 30®C. Top to bottom: DSPC, C1 2 E1 , C1 2 E3 , 
C 1 2 E 5 ,  C 1 2 E 7 .
153
0.90
_  0 .8 0 -
co
0.70 -





°  0.40 -
X-
0.30
0.0 1.0 2.0 3.0 4.0 5.0 6.0 7.0 8.0 9.0
Number of ethoxy groups
Figure 5.7 Values of S for 5-DS incorporated into DSPC/Ci2 En mixed vesicles 
containing 9 mole% surfactant plotted as a function of surfactant ethoxy chain 
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Figure 5.8 Values of S for 5-DS incorporated into DSPC/Ci2 En mixed vesicles 
containing 33 mole% surfactant plotted as a function of surfactant ethoxy chain 
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Figure 5.9 Values of S for 5-DS incorporated into DSPC/C1 2 E11 mixed vesicles 
containing 50 mole% surfactant plotted as a function of surfactant ethoxy chain 
length. Measurements were made at 30®C. Points are mean±SD, n —4
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however there were no statistical differences between the effects of C1 2 E4 -C1 2 E8  
inclusive (t-test, p<0.05). The addition of 33 mole% surfactant to the DSPC 
liposomes produced a large decrease in S with all ethoxy chain lengths except C 1 2 E 1 
which caused no significant change. C 1 2 E2 -C1 2 E8  all reduced S to a value of about 
0.525. The longer ethoxy chains C1 2 E7  and Ci2 Eg produced greater changes in S to 
0.468 and 0.465 respectively. A similar structure-activity relationship to that 
observed at 33 mole % surfactant was produced by the addition of 50 mole% 
surfactant to the DSPC liposomes. The value of S was reduced to a greater extent 
by the higher surfactant concentration. This was very noticeable for samples treated 
with C1 2 E 1 . The results for all three concentrations are summarised in Figure 5.10 
where the effect of each surfactant is expressed as mean percentage decrease in S 
with respect to the control value obtained in the absence of surfactant.
Figure 5.11 shows the effect of concentration of C1 2 E3  upon the order 
parameter of 5-DS in DSPC liposomes. There was a slight decrease in S with the 
addition of up to 20 mole% C1 2 E3 . Increasing the concentration of C 1 2 E3  above 
this level caused the value of S to decrease more rapidly. At 50 mole% surfactant S 
had fallen to 0.528±0.(X)5. Further increase in surfactant concentration had little 
effect upon the value of S.
5.3.2 Isolated Stratum Comeum
A typical spectrum for 5-DS incorporated into hydrated porcine stratum 
comeum is shown in Figure 5.12. The spectra had very broad lines. The hyperfine 
splittings obtained from the spectra were 33.67+0.48 and 10.86+0.15 for A^ and 
A_l respectively. For untreated stratum comeum the order parameter of the 5DS 
probe was calculated to be 0.667+0.0015 (mean+sd, n=3).
Treatment with surfactant narrowed the spectral lines and reduced Ajj. 
There was little change in the value of Aj_. A typical spectrum for surfactant 
treated stratum comeum, in this case C1 2 E3 , is shown in Figure 5.13. The 
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Figure 5.11 The effect of increasing surfactant concentration upon S for 5-DS in 
DSPC/C1 2 E3  mixed vesicles at 30°C. Mean±SD, n=4.
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Figure 5.13 ESR spectrum for 5-DS incorporated into hydrated porcine stratum 
comeum treated with C1 2 E3  at 30®C.
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treated with € 1 2 ^ 0 "^ 1 2 ^  are shown in Figure 5.14 plotted as a function of 
surfactant ethoxy chain length. All surfactants reduced S to between 0.565 and 
0.610, a significant decrease in the order parameter with respect to untreated 
stratum comeum (t-test, p<0.05). However there were no significant differences 
in the values of S obtained with the different surfactant (t-test, p>0.05).
5.4 DISCUSSION
The ESR spectra observed were normal for nitroxide fatty acid probes 
undergoing anisotropic motion in membranes. Each sample gave highly
reproducible spectra, less than a 3% change in hyperfine splittings being observed 
between repeated spectra. A greater variation was observed between samples. This 
indicated that the majority of experimental variation occurred during sample 
preparation and not in the measurement of the spectra.
The spectra observed for 5-DS in pure DSPC liposomes at 30°C were 
typical for this type of probe in a relatively immobile state. Similar spectra have 
been reported by several other investigators working with 5-DS and similar probe 
molecules (161-163). At 30®C pure DSPC membranes were in a gel crystalline 
state with the lipid acyl chains packed in an ordered fashion. The probe molecule 
would therefore have been highly constrained and would have undergone little 
movement. The hyperfine splittings obtained in pure DSPC liposmes were in 
accordance with previously reported values for 5-DS in gel phase lipids. Marsh et 
al (157) studied 5-DS in DPPC liposomes. At temperatures below the gel-liquid 
crystalline phase transition a value of approximately 30.4 Gauss was obtained for 
Aji. Above the phase transition temperature, when the lipid is in a liquid crystalline 
phase this value was reduced to 26.8 Gauss.
In this present study an order parameter of 0.679+0.54 was determined for 
5-DS in DSPC liposomes. This was typical for this probe in gel phase lipids 
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Figure 5.14 Values of S for 5-DS incorporated into porcine stratum comeum treated 
with Ci2 En plotted as a function of surfactant ethoxy chain length. Measurements 
were made at 30®C. Points are mean±SD, n=4
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the order parameter of 5-DS in the liposomes at 30°C. This was mainly due to 
large decreases in the value of A^.
The change in the was accompanied by a narrowing of the spectral lines. 
Both of these effects have been reported to be associated with an increase in the rate 
of rotation of the probe molecule around its long molecular axis (162,165). The 
value of A_j_ also increased with the addition of surfactant. This was due to 
increased averaging of the hyperfme splitting (see 5.1.1) and probably an increase 
in the freedom of motion of the probe. Increased values of S indicate more 
molecular wobble of the probe, i.e. an increase in the angle of movement of which 
the probe can undertake around the molecular long axis as the probe sits in the 
bilayer (162). The changes in lipid packing caused by the surfactants and the 
manner in which surfactants act upon membranes has been discussed previously (see
3.4 and 4.4).
The decrease in order parameter indicated that addition of surfactant to the 
DSPC bilayers caused a decrease in the order of packing of the lipids i.e. 
fluidisation of the bilayers. This allowed the increased motion discussed above. 
Similar results were obtained with Brij 36T (C1 2 E 1 0 ) and oleic acid by Gay et al 
(163).
The effect of the surfactant upon the bilayers in this ESR study is in 
agreement with the findings of the DSC and EPS studies reported in Chapters 3 and 
4 in that the surfactants caused bilayer fluidisation, however a different structure- 
activity relationship was indicated by the nitroxide probe. When analysed by DSC 
the most potent surfactant for fluidisation of DSPC bilayers when present at a 
concentration of 50 mole% was C1 2 E3 . When analysed by EPS the structure- 
activity relationships regarding apparent bilayer fluidisation in the 1 : 1  surfactant 
lipid systems were dependent upon the fluorescent probe structure. The position of 
the probe in the bilayer was of consequence in these studies. DPH which sits in the 
membrane interior was affected to the greatest extent by C 1 2 E4 , whilst ANS a 
'headgroup' probe was affected more by the higher ethoxy chain length molecules
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around Ci2 E6 - Cis-pna is a C^ g fatty acid and would therefore be expected to sit in 
the membrane in a similar orientation to 5-DS and produce results in parity with 
5-DS with respect to surfactant efficacy. This however was not the case, with cis- 
pna C1 2 E5  was shown to be the most potent membrane fluidiser in terms of reducing 
Tg, with increasing T^ and reducing probe anisotropy r. In the ESR study the 5-DS 
order parameter decreased with surfactant ethoxy chain length, C 1 2 E7  and Ci2 Eg 
were observed as the most potent membrane fluidisers amongst the surfactant series 
above 33 mole% surfactant.
The difference in the results of the EPS and ESR experiments was thought 
most likely to be due to the differences in structure of the probes. 5-DS is reported 
to detect changes in fluidity in the membrane just below the polar head groups of 
the molecules (149,163). This is due to the position of the doxyl group upon the 
acyl chain. The fluidity changes reported by cis-pna may have been affected by 
changes in the order of acyl chain packing deeper in the membrane. The longer 
ethoxy chain surfactants Ci2 E6 -Ci2 Eg may have caused greater disruption in packing 
of the polar headgroups than C1 2 E4 -C1 2 E5 . The relative increase in membrane 
fluidity caused by Ci2 E6 -Ci2 Eg would thus be greater when observed with 5-DS 
than with cis-pna. This theory would in part be supported by the results observed 
for the EPS of ANS, a headgroup probe when the surfactants with longer ethoxy 
chain lengths were seen as relatively effective membrane fluidisers.
As suggested in the discussion of the EPS studies (see 4.4) the membrane 
probe may partition into areas of localised fluidity caused by phase separation in the 
membrane. The probe could have also become incorporated into surfactant micelles 
with the micellising surfactants which would be a more fluid environment. These 
possibilities have to be considered when comparing the results from the EPS and 
ESR studies with those obtained by DSC.
The spectra observed for 5-DS incorporated into the extracellular lipid 
lamellae of the stratum comeum show the probe to be highly immobile in the 
membrane. The spectral line widths were very broad and a relatively high value of
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s  (0.667+0.00015) was obtained from the hyperfme splittings. These parameters 
indicated that the acyl chains of the lipids in the intercellular lamellae were highly 
ordered and tightly packed. The shape of the ESR spectra and the value of S were 
in close agreement with a similar study upon 5-DS in human stratum comeum by 
Gay et al (166). It should be noted that different formulae were used for the 
calculation of the order parameter in the two studies. Recalculation of the results of 
this study according to the equation used by Gay et al show the two values of S, one 
in porcine and the other human stratum comeum, to be extremely close.
Treatment of the stratum comeum with surfactant greatly changed the ESR 
spectra. The spectral lines narrowed and became more pronounced. The value of S 
decreased, mainly due to a decrease in Ajj. These changes indicated increased 
molecular motion of the probe and fluidisation of the lipid bilayers as discussed 
previously for DSPC liposomes. All the surfactants produced a decrease in the 
order parameter to values between 0.565 and 0.610. This was a decrease in S of 
between 8 . 6  and 15.4 percent of the value obtained in untreated stratum comeum. 
There were no significant differences between the effects of the different 
surfactants. This decrease in S observed was in parity with results obtained by Gay 
et al (166). They reported a 14.7% decrease in the value of S for 5-DS in human 
stratum comeum that had been treated with Brij 36T (C1 2 E1 0 ). The investigators 
concluded that the Brij 36T caused bilayer fluidisation in the skin.
The results from the liposome and stratum comeum studies did show some 
correlation with respect to surfactant treatment. It is not east to make direct 
comparisons between the two techniques. In the liposome studies both the degree of 
fluidisation and structure-activity relationship changed with the concentration of 
added surfactant. In the stratum comeum studies it was unknown how much 
surfactant would have penetrated into the lipid lamellae. It is likely the surfactants 
would have penetrated the stratum comeum at different rates. The molecules with 
shorter ethoxy chain lengths were expected to permeate the skin more readily than 
the hydrophilic molecules (32). After 24 hours there would be more of the lower
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HLB molecules present in the lipid bilayers of the skin preparation than longer 
chain molecules. In the liposome studies the same amount was added for each 
surfactant, although it is unknown exactly how much partitions into the membrane. 
The higher efficacy of C 1 2 ^ 6 -0 i2 Eg observed in DSPC bilayers (Figures 5.3.4, 
5 .3 .5 ) may be counteracted in the stratum comeum investigations by the relatively 
poor permeation of these surfactants. This is assuming that the 5-DS probe sits in 
the membranes at the same position in both preparations, as this would have bearing 
on the structure-activity relationship.
Studies using ESR in stratum comeum have great potential for investigating 
percutaneous absorption of drugs and the relative efficacy of penetration enhancers. 
The rate of molecular movement in the stratum comeum can be measured for any 
molecule with unpaired spin or a spin label moiety attached to it. It may be 
possible to synthesize spin labelled analogues of drug with potential for transdermal 
delivery. The molecular movement, which is related to ease of diffusion through 
the membrane, could be easily measured by ESR. The effect of any potential 
penetration enhancers upon this molecular motion could be quickly screened.
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CHAPTER 6
MEASUREMENT OF THE PENETRATION 




In order to assess the potency of penetration enhancers it is ultimately
necessary to measure the percutaneous absorption of drug compounds in the
presence and absence of the enhancing agent.
These experiments ideally would be carried out in-vivo using human
volunteers, plasma drug concentrations being assayed over a period of time. 
Several studies of this type have been carried out using radiolabelled material (30) 
when excreted label was used as a measure of percutaneous absorption, due to the 
very low plasma concentrations achieved. Human in-vivo experiments, however, 
may have ethical, financial and toxicological problems. An alternative is the use of 
animal models in-vivo. These may cause extra problems due to skin differences 
between the animal and man, and will still suffer from the biological variability and 
complex biological factors which are difficult to control in all in-vivo studies (see 
Chapter 1).
Many of the problems of variability, and high cost can be avoided by the use 
of in-vitro techniques using excised skin. In in-vitro experiments there is an 
assumption that the non viable stratum comeum functions as the major permeability 
barrier in both living and dead skin. Human skin would be the ideal choice for 
in-vitro studies, however, a regular, consistent supply of good human skin is often 
hard to obtain so animal models are often used. Porcine skin has been shown to be 
one of the best models for human skin (see chapter 1).
Many different techniques have been used for in-vitro studies of 
percutaneous absorption. To assess the relative potency of the surfactant series 
C1 2 E0 -C1 2 E8  penetration enhancers, the permeation of the steroids oestradiol 
(OE), hydrocortisone (HC), oestrone (OT) and progesterone (PG) through porcine 
ear skin was determined in the presence and absence of each surfactant. It was 
decided to use a 'finite dose' technique in which both the permeant and the enhancer 
were deposited as a thin film onto the skin surface from a volatile solvent. This 
technique has been used in similar studies (59). It was thought these methods would
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as far as possible avoid complication of the data due to complex vehicle/drug, 
vehicle/skin interactions.
6.2 METHODS
6.2.1 Preparation of Thin Skin Membranes for Permeation Experiments.
Porcine ear skin was obtained and stored as described previously (2.1). For 
the preparation of membranes for permeation studies samples were allowed to thaw 
slowly at room temperature. Circular discs were then punched out of the skin using 
a sharpened number 16 cork borer. This produced discs of whole skin 
approximately 2.6cm diameter. These discs were then placed stratum comeum 
down onto aluminium plates which had been cooled to -70°C. All subcutaneous fat 
and most of the dermis was removed from the sample to leave a preparation 
comprising of the epidermis and a thin layer of dermis. The whole preparation was 
0.8mm thick. The prepared membranes were then washed in distilled water and 
blotted with tissue paper to remove residual water from the skin surface.
6.2.2 Diffusion Experiments
The prepared skin membranes were mounted into glass, horizontal, static 
diffusion cells, stratum comeum uppermost, as shown in Figure 6.1. The receptor 
compartment was filled with a known volume (approximately 4.5ml) 20% (^/y) 
ethanol in pH 7.4 PBS. Ethanol was added to the receptor fluid in order to increase 
the solubility of the steroids in this phase and thus maintain sink conditions.
The labelled steroids were prepared in acetone as described in 
Chapter 2. For application to the skin 20^1 of the steroid solution was pipetted onto 
the skin surface. The solution was spread evenly over the skin by agitation and 
repeated pipetting. The acetone was then evaporated under a gentle stream of 
nitrogen gas. For each cell 0.1/xCi of steroid were applied to the skin this 
corresponded to 98^g total steroid of OE and 130^g of HC. For OT and PG 0.2/d 
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Figure 6 .1 Schematic diagram of skin mounted in a horizontal diffusion cell.
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The surfactant was applied in 20^1 of acetone by the same method and at the 
same time as the steroid so as to codeposit the surfactant and steroid on the skin 
surface. For each experiment 2.2x10'^ moles of surfactant were applied to the skin 
except where stated. This corresponded to O.Smg of C 1 2 E4 . For control 
experiments in the absence of enhancer, 2 0 ^ 1  of acetone was pipetted with the drug 
onto the skin surface.
The cells were mounted over underwater magnetic stirrers in a water bath at 
32®C. This produced a skin surface temperature of 30± 1°C. The skin surface was 
left open to the laboratory atmosphere. The receptor fluid was constantly stirred to 
prevent the development of static layers under the skin. 1 ml samples were taken 
from the receptor fluid periodically over 90-100 hours. The samples were replaced 
with 1ml of fresh prewarmed ethanolic PBS. The samples collected were analysed 
by liquid scintillation counting.
6.2.3 Construction of a Quench Calibration Curve
In order to calculate the mass of steroid in the receptor fluid it was necessary 
to obtain the radioactive count in terms of disintegrations per minute (dpm). The 
LKB Rackbeta II used had an inbuilt dpm package which utilised the channels ratio 
method of quench correction with an external standard. In order to use this package 
a quench calibration curve was constructed by the 'hat-trick' method (LKB Wallac, 
Sweden) in which quenching agent, (carbon tetrachloride) was continuously added 
to a volume of scintillant containing a radioactive sample, via a filter paper wick 
whilst the sample was repeatedly counted. The dpm package then interpolated a 
calibration curve using a spline function from which a counting efficiency was 
obtained from the calculated channel ratio. The curve obtained and used in the 









Figure 6.2 Quench calibration curve for in 10ml Optiphase scintillation 
cocktail.
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6.2.4 Liquid Scintillation Counting of Samples
Each 1ml sample taken from the diffusion experiments was pipetted into a 
20ml plastic scintillation vial, 9ml of scintillation cocktail (Optiphase; Pharmacia 
Sweden) was added to the sample and the vial shaken to produce a single phase. 
The samples were then counted for 180 seconds using a LKB 'Rackbeta IP 
(Pharmacia) liquid scintillation counter.
6.2.5 Calculation of Results
For each diffusion cell the cumulative mass of steroid in fig penetrating unit 
area of skin was calculated, corrections being made for dilutions used at sampling. 
These calculated values were plotted against time. From these plots the mass of 
steroid that had permeated through the skin after 24, 48, 60 and 72 hours was 
determined. The effectiveness of each surfactant as a penetration enhancing agent 
was determined by comparing the mass of steroid that penetrated surfactant treated 
skin to that for untreated skin. This can be defined as the enhancement ratio (ER) 
such that:
_  (Mass of steroid penetrating surfactant treated skin in time t)
(Mass of steroid penetrating untreated skin at time t)
where t is the time from initial drug-skin contact.
Pseudo steady state flux in terms of f i g  cm'^hr"^ was obtained from linear 
portions of the plots after the effect of acetone deposition had subsided; generally 
after 30 hours. For surfactant-enhanced hydrocortisone penetration it was not 





For all four steroids a channels ratio of approximately 1.35 was 
obtained. From the quench correction curve this showed the counting efficiency to 
be around 8 6 %.
6.3.2 Permeation of Oestradiol
Figure 6.3 shows a typical permeation profile for oestradiol through pig ear 
skin in the absence of surfactant. There was little or no lag time before the 
appearance of OE in the receptor fluid. The initial flux over the first 30 hours was 
0.0206+0.005 (mean+SD, n = 6 ) fig cm ^hrL Flux decreased over the next 10 
hours to 0.0135 ±0.004/ig cm-^ hr^ after 40 hours and remained constant at this 
value until termination of the experiment. The amount of OE that penetrated the 
skin after 24, 48, 60 and 72 hours was 0.57+0.026, 1 .06±0.055, 1.22±0.095 and 
1.39+0.125 jLig cm-2 respectively.
Application of surfactant to the skin greatly increased the mass of OE 
penetrating the skin. Figure 6.4 shows permeation profiles for OE penetration 
through pig skin in the presence of C 1 2 E1 , C 1 2 E3 , C1 2 E5  and C1 2 E7 . All the 
surfactants produced a similar shape permeation profile over the time course of the 
experiment with the exception of C 1 2 E0 , which caused a profile similar in shape to 
unenhanced permeation. C1 2 E 1 and C 1 2 E2  which showed some reduction in the rate 
of enhanced flux after 45 hours.
The extent of penetration enhancement was highly dependent upon the 
ethoxy chain length of the surfactant. Figure 6.5 shows the cumulative amounts of 
OE permeated after 24 hours plotted against the ethoxy chain length of the 
surfactant. The points shown are mean and standard deviation of four observations. 
As ethoxy chain length of surfactant increased from C1 2 E0 -C1 2 E3  the amount of OE 
permeated also increased to a maximum with C1 2 E3  treated skin. C 1 2 E3  increased 
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Figure 6.3 Typical permeation profile for oestradiol through unit area of porcine 
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Figure 6.4 Permeation profiles for the penetration of oestradiol through 1 cm’^  of 
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Figure 6.5 Cumulative mass of oestradiol that permeated 1 cm*^  of surfactant 
treated skin after 24 hours plotted as a function of the surfactant ethoxy chain 
length. Mean±SD, n=4
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chain length of the surfactants from C 1 2 E3 -C1 2 E8  reversed this trend, the amount of 
OE that penetrated the skin decreased with surfactant ethoxy chain length.
Figure 6.6 shows the mean cumulative OB permeation for unenhanced skin 
and skin treated with surfactant for four skin samples at 24, 48, 60 and 72 hours. 
Time is plotted on the z-axis into the plot. The structure-activity relationship 
observed after 24 hours became more distinct as time of penetration increased, 
22.82+5.31 cm-2 of OE having penetrated C1 2 E3  treated skin after 72 hours.
Figure 6.7 shows calculated pseudo steady state flux values for surfactant 
treated skin. The points shown are mean and standard deviation for four skin 
samples. All fluxes were calculated by linear regression of permeation profiles 
between 40-80 hours. All had linear correlation coefficients (r) >0.95.
6.3.3 Permeation of Hydrocortisone
A typical plot for cumulative hydrocortisone permeation through pig skin in 
the absence of surfactant, is shown in Figure 6 .8 . The permeation of HC showed 
little to no lag time under the conditions used, radioactive material was detected in 
the receptor fluid after two hours.
HC flux was at a maximum immediately after the lag period and then 
decreased continually with time until approximately 40 hours when a pseudo-steady 
state flux of 0.008+0.0012 /xg cm--hr"i was reached. This rate of permeation 
remained unaltered until the end of the experiment. The amount of HC that 
penetrated the skin after 24, 48, 60 and 72 hours was 0.73 +0.53 , 0.99 +0.62, 
1.09+0.65 and 1.19+0.68 /xg cm-^ respectively.
Application of all surfactants investigated to the skin increased the 
penetration of HC through the skin. The effect observed was highly dependent 
upon the surfactant ethoxy chain length. Figures 6.9 and 6.10 show the permeation 
profiles for HC through skin in the presence of C 1 2 E0 -C1 2 E8  respectively. The 
relationship between the mass of steroid that permeated the skin and time, the 
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Figure 6.7 Calculated pseudo steady state flux values for the permeation of 
oestradiol through surfactant treated skin plotted as a function of surfactant ethoxy 
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Figure 6 . 8  Typical permeation profile for the penetration of hydrocortisone through 
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Figure 6.9 Permeation profiles for the penetration of hydrocortisone through 1 cm'^ 
o f  porcine ear skin in the presence of C 1 2 E1 (o), C1 2 E3  (□), C1 2 E5  ( a )  and 




















0 2 0 40 60 80 100
Time (hr)
Figure 6 .10 Permeation profiles for the penetration of hydrocortisone through 1 
cm- 2  o f  porcine ear skin in the presence of CioEq ( o ) ,  ^12^  (o), C1 2 E4  ( a )  
^ 1 2 ^ 6  (^) ^ 1 2 ^  (*)•
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oxide groups per molecule increased from Ci2 Eo"^i2 ^  the time taken to reach 
maximum hydrocortisone flux increased. In addition the duration of the surfactant 
induced enhanced flux lengthened. For example C 1 2 E 1 caused maximum flux of 
HC across the skin to be reached after 4 hours, this maximum rate was maintained 
until 10 hours after steroid application. The HC flux then decreased continually to 
a level almost equal to the untreated skin after 40 hours. However, with Ci2 Eg 
maximum flux was not reached until 40 hours after application and was maintained 
until the end of the experiment. These effects influenced the amount of drug 
penetrating the skin with time. This is illustrated in Figure 6.11. The bar graph 
shows the mean mass of HC, (n=3) that permeated the skin after 24, 48, 60 and 72 
hours plotted against surfactant ethoxy chain length on the x-axis; time is plotted on 
the z-axis into the page. Considering the graphs as a function of increasing ethoxy 
chain length over the range C1 2 E0 -C1 2 E8 ; at 24 hours there was a sharp rise in the 
mass of HC penetrated to a maximum at C1 2 E3  and then an equally sharp decline to 
a minimum with Ci2 Eg. As time of permeation increased the effects of longer 
ethoxy chain enhancers became more pronounced. After 72 hours there was little 
difference between the amount of HC penetration with C1 2 E3 , C1 2 E4  and C1 2 E5  and 
only slightly less permeated with C1 2 E6 -C1 2 E8 . The amount of HC permeated in 
the presence of C1 2 E0 -C1 2 E2  had increased only slightly after 24 hours. These 
values are summarised in Figure 6.12, which shows the amount of HC permeated 
after 72 hours plotted against surfactant ethoxy chain length. The points are 
mean±standard deviation for 3 skin samples.
Figure 6.13 shows the effect of the application of increasing amounts of 
C 1 2 E3  upon the permeation of HC through porcine ear skin. As the mass of 
surfactant applied to the skin increased so did the mass of hydrocortisone 
penetrating the skin. The initial rates of flux were very similar for all amounts of 
C 1 2 E3  up to 4.4 X 10*^  moles but the duration of the period of maximum flux 
lengthened with increased amounts of C1 2 E3 . With the two largest amounts of 
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Figure 6.12 Cumulative mass of hydrocortisone that permeated 1 cm* 2 o f  
surfactant treated skin after 72 hours plotted as a function of the surfactant ethoxy 










0 20 40 60 80 100 120
Time (hr)
Figure 6.13 The effect of application of increasing amounts of C 1 2 E3  upon the 
permeation of hydrocortisone through 1 cm'^ o f  porcine ear skin. 0 . 5 5  (•) 
1.1 (A), 2.2 (■), 4.4 (o), 8 . 8  (□) and 17.6 ( a )  moles xlQ-  ^C1 2 E3 .
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4.4x10*^ moles, and the amount of steroid penetrating the skin did not exceed the 
amount that permeated with less surfactant until 35 hours after application.
6.3.4 Oestrone and Progesterone Permeation
Figure 6.14 and 6.15 show the respective permeation profiles for oestrone 
and progesterone penetration through porcine ear skin with and without application 
of C1 2 E3 . The points shown are mean and standard deviation of 3 skin samples.
The pseudo steady state flux values, the amount of steroid that permeated the 
skin at 24, 48, 60 and 72 hours and the enhancement ratios calculated from these 
values are given in Tables 6.1 and 6.2.
6.4 DISCUSSION
There has been a considerable volume of work published by many authors 
on the permeation of steroids through skin. It is difficult however to make direct 
comparisons to other researchers work as invariably different investigations have 
used different methods, different skin preparations and different species of animal 
skins. In making reference to other work in this field, the limitations involved in 
extrapolating between systems must be taken into account.
The permeation of the four steroids used in this study through porcine skin, 
without enhancement, all produced a similar shaped penetration profile with time. 
The rate of penetration of each steroid was however different. In each case there 
was short lag time ( < 8 hr) before maximum flux was reached. Other works have 
quoted longer lag times for steroid diffusion through the skin, especially in the case 
of the more polar steroid HC (35). This may indicate that initial flux is controlled 
by "shunt pathway" diffusion for the polar steroids (29) or may be a consequence of 
the method of steroid application. A small fraction of the acetone solution applied 
to the skin could penetrate the appendages before evaporation of the solvent. Any 
steroid deposited directly over the appendages would also penetrate the skin rapidly. 
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Figure 6.14 Permeation profiles for the penetration of oestrone through 1 cm'^ o f 
porcine ear skin in the absence (•) and presence (■) of C 1 2 E3 . Mean±SD, n=3.
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Figure 6.15 Permeation profiles for the penetration of progesterone through 1 cm’^  
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respect to permeation through the whole stratum comeum due to effective depletion 
of the drug within the appendages. Lateral diffusion in the dry steroid film would 
be negligible.
After the initial burst of steroid flux across the skin the flux constantly 
decreased over the next 30 hours to a pseudo steady state level after approximately 
40 hours which continued until the end of the experiment. These observations can 
be explained by the shunt route flux described above and the evaporation of acetone 
from the skin surface. After application of the steroid in acetone the solvent 
remains visable on the skin for approximately two minutes. As acetone evaporated 
the steroid would be deposited as a film on the skin surface.
In the initial moments of contact the steroid is in solution and the flux into 
the skin would be determined by the stratum comeum/acetone partition coefficient. 
As solvent evaporated the chemical potential of the steroids increased. At the 
saturation point of the steroid in acetone, the driving force for partitioning into the 
skin was maximal. The optimal partitioning continued until the acetone completely 
evaporated leaving solid steroid on the skin. The initial burst of penetrant 
partitioning into the skin provided a peak flux, this was also likely to cause the 
build up of a reservoir of steroid in the stratum comeum. The reservoir effect in 
steroid percutaneous absorption is a well documented phenomenon (167). The 
decrease in flux following the initial maximum was probably due to the depletion of 
this resevoir and as dissolution of the penetrant from the deposited film became the 
rate limiting step in the percutaneous absorption of the steroid.
This theory is supported by the fact that application of 20/^ 1 of acetone to a 
film of hydrocortisone on the skin surface after 40 hr caused a second burst of 
steroid flux through the skin presumably by redissolving the steroid and increasing 
the partitioning of drug into the skin (results not shown).
The use of acetone as a vehicle to deposit drug on the skin surface has been 
demonstrated to have damaging effects upon the permeability barrier in hairless 
mouse skin (168). The same study showed however, that human cadaver skin was
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not significantly affected by the solvent. As porcine stratum comeum is more 
similar in nature to human than hairless mouse skin, it was thought unlikely that 
acetone would damage porcine skin preparations, especially as the amount used 
(11.4 fil cm-^) was significantly less than the 160 /xl cm-  ^used by Bond and Barry in 
the above mentioned investigation.
The pseudo steady state flux values calculated for all four steroids, without 
enhancement, were made between 40-80 hr after drug application, this was after the 
initial acetone affected drug flux had subsided. Table 6.3 gives the compiled data 
for the fluxes of the four steroids used. The rate of penetration of the steroids 
decreased in the order progesterone > oestradiol = oestrone = hydrocortisone 
(t-test, p> 0.01). This order would be expected from human stratum 
comeum/water partition coefficients calculated by Scheuplein et al (35). These 
values of 104, 46, 46 and 7 for PG, OE, OT and HC respectively would be 
expected to give an estimation of the expected penetration of the steroids into the 
skin. The same investigation calculated permeability constants (kp) from aqueous 
solutions and also maximum obtainable fluxes from saturated aqueous solutions for 
the four steroids used in this study through human cadaver skin. The kp values 
obtained were 3600, 1500, 300 and 3 cm hr^xlO*^ for OT, PG, OE and HC 
respectively, a different order to this study. The calculated maximum fluxes gave a 
different picture again, with PG, OT, HC and OE producing values of 0.0128, 
0.046, 0.(XX)8 and 0.(XX)34/ig cm-^hr^ respecitvely. These latter flux values are 
between 2  and 1 0  fold less than the flux values obtained in this work with the 
exception of oestradiol which showed a 40 fold greater permeability in this study 
with respect to the calculations of Scheuplein et al.
In an in-vivo study upon steroid permeation through human forearm skin, 
Feldman and Maibach (30) found similar amounts of PG and OE penetrated the skin 









Table 6.3 Pseudo steady-state fluxes of oestradiol, hydrocortisone, oestrone and 
progesterone through porcine ear skin. (mean±SD, n>3)
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Barry and Bennet (58) stated fluxes of 0.0237±0.0063 ng cm-^ hr^ for HC 
and 0.0467+0.0089 fig cm-^ hr^ for PG through human epidermis, using an 
acetone deposition method similar to this study. Using similar methods and 
conditions Goodman and Barry (59) quoted an average flux of 0.025/xgcm-2hri for 
OE this included the 'acetone burst'. These three values are similar to those 
obtained in this work. Moelgaard and Hoelgaard (169) found OE deposited as a 
film from ethanol to have a steady state flux of 0.011±0.(X)4 fig cm-^ hr^ through 
human skin which is the same as obtained in this investigation. Ponec and Polano 
(170) investigated the permeation of hydrocortisone from an ethanolic solution 
through human skin. They did not calculate a flux value, but quoted that 7.45/^g of 
HC permeated the skin in 72 hours compared to 1.19+0.68 fig in this study.
All nine surfactants caused some increase in the amount of steroid 
penetrating the skin. In the case of HC permeation, there was a difference in the 
amount of enhancement and shape of the permeation profiles between the members 
of the surfactant series. As the length of the ethylene oxide chain increased so did 
the time to reach maximum flux and the duration of action in the skin. The low 
ethoxylated molecules showed permeation profiles with a rapid initial flux reducing 
with time to a constant rate of steroid permeation. This shape of permeation curve 
would be consistent with drug depletion from the skin surface or from an initially 
set up reservoir, decrease in the thermodynamic activity of the steroid, steadily 
increasing resistance to penetration in the skin or reduction in enhancement effects 
due to surfactant depletion.
The last of these suggestions was the most likely cause of this profile shape. 
Increasing the amount of surfactant (C1 2 E3 ) on the skin surface did not alter the rate 
of the initial maximum flux but did increase the duration of the period of maximum 
flux of HC (see Figure 6.13).
If it is assumed that the surfactant has to be present in the stratum comeum 
to exert an enhancement effect, it could be concluded from these results that the low 
HLB surfactants rapidly permeate through the skin and effectively deplete the
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amount of enhancer. As the length of the ethoxy chain increased, the rate of 
surfactant depletion decreased and with C1 2 E7  and C^2 ^ 8  maximum flux is observed 
until the termination of the experiment. As the maximum flux is reached more 
slowly with the longer ethoxy chain lengths, it may suggest that as the ethoxy chain 
length of the surfactant increased, the rate of permeation of the surfactant molecules 
across the skin decreased. The low HLB molecules would thus exert a rapid but 
short lived action and the higher HLB molecules would give a slower but more 
prolonged action.
This suggestion is consistant with the findings of Nishiyama et al (32) who 
studied the permeation of dodecyl ether ethoxylates in the range C1 2 E0 -C1 2 E1 0  
across hairless mouse skin in-vivo. They found C 1 2 E0  to have the highest rate of 
absorption of 0.12 ^mole cm ^hr^ (22.32 fig cm-^hr^). A comparable rate through 
pig skin would mean all the applied surfactant would permeate through the skin in 
only 18 hours, it is however likely that pig skin is less permeable than hairless 
mouse skin. As ethoxy chain length of the surfactant increased the rate of 
percutaneous absorption decreased C 2^ ^i ^ 1 2 ^ .6  (average ethoxy chain length)
had similar flux values of 0.097 fimo\t cm-^hrL This would mean complete 
absorption of the 2.2x10'^ moles of surfactant in approximately 22.7 hours. A flux 
value of 0.0075 /xmole cm-^hr^ was reported for C 1 2 E 1 0 » would take 293 hours to 
completely permeate 2.2x10'^ moles through the skin. The authors also found that 
there was almost no lag before C1 2 E0  penetrated the skin and as ethoxy chain length 
of the surfactants increased, so did the time to reach the maximum rate of 
permeation. Similar findings were made by Black and Howes (62) who reported 
the permeation of C1 2 E3  and to be far greater than that of C1 2 E1 0  through rat 
skin in-vitro.
The presence of surfactant on the skin surface may also have affected the 
availability of the drug for percutaneous absorption. After evaporation of the 
acetone the steroid will be present in a crystalline form. In order to diffuse into the 
skin the drug would have to dissolve in either the sebum or directly into the stratum
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comeum lipids. There may have been limited contact between available steroid and 
the skin surface. The steroid crystals may have dissolved in the film of surfactant 
present on the skin surface. This would have increased the effective contact 
between the steroid and skin surface relative to crystalline drug. Surfactant 
depletion due to their penetration through the skin would result in recrystallisation 
of the steroid and therefore a decrease in the extent of the improved contact. These 
effects would have been dependant upon the solubility of the steroid in the 
surfactant and the rate of depletion of surfactant from the skin surface. As there 
was only an initial 1:7 molar ratio of drug to surfactant present upon the skin 
surface it is expected that most of the drug would not have dissolved. The 
thermodynamic activity of the steroid would not have been reduced by the 
surfactant. C1 2 E5 -C1 2 E8  may have kept the steroid in solution for a longer period 
of time than the shorter ethoxy chain molecules, but these may have been better 
solvents for the steriod. The extent these effects had upon the drug penetration rate 
is unknown.
The surfactant depletion effects were very prominent in the enhancement of 
HC penetration but for OE with the exception of C1 2 E0  there was little difference in 
the shapes of the permeation profiles between surfactants. This can be seen more 
clearly by looking at the enhancement ratios (ER) at 24, 48, 60 and 72 hours for 
OE and HC, Figures 6.16 and 6.17 respectively. In the studies with HC there is a 
decrease in ER with time for the surfactant range C1 2 E0 -C1 2 E3 , an increase in ER 
up to 48 hours and then a decrease for C1 2 E4 , an increase up to 60 hours then a 
decrease for C1 2 E5  and C1 2 E5  and a continual increase in ER with time for C1 2 E7  
and Ci2 Eg. For OE enhancement a continual increase in ER with time is seen for 
all surfactants except C1 2 E0  which shows a continual decrease, however the extent 
of the increase in ER with C 1 2 E 1 and C1 2 E2  is smaller after 60 and 72 hours 
compared with higher HLB surfactants.
The enhanced permeation of both oestrone and progesterone by C 1 2 E3  














































































































This suggests that the enhancement of the more lipophilic molecules PG, OT and 
OE may have occurred at either a different site of action, by a different mode of 
action or with a different concentration dépendance with respect to the more 
hydrophilic HC.
For both OE and HC maximum penetration enhancement was observed with 
C1 2 E3  however the extent of enhancement by this surfactant differed for the two 
steroids as did the relative effects of the other members of the surfactant series. 
C1 2 E3  produced an ER2 4  of 11.0 for OE permeation and 17.7 for HC penetration. 
These ratios altered with time to produce ER7 2  values of 16.4 and 15.5 for OE and 
HC respectively. The ER2 4  for OT and PG were 2.7 and 4.7, after 72 hours (ER7 2 ) 
then had become 3.4 and 4.9 respectively. This made the order of enhancement of 
the four steroids by C1 2 E3  H O O E > P G = O T  at 24 hours and at 72 hr 
O E=H C>PG=OT (t-test, p>0.05).
Figures 6.16 and 6.17 also show the distribution of enhancement ratios 
around the maximum value obtained with C1 2 E3 . For OE and HC this distribution 
differs to a great extent. For OE the ER2 4  showed a skew to the low ethoxy content 
molecules, C 1 2 E 1 and C 1 2 E2  were more potent enhancers than C1 2 E4  and C 1 2 E5 . 
After 72 hours this skew has evened up and the ER7 2  were similar for C 1 2 E2 /C 1 2 E4  
and C1 2 E 1 /C 1 2 E5 . C1 2 E0  and C1 2 E6 -C1 2 E8  gave far lower ER values.
For HC the distribution around C 1 2 E3  is skewed towards the more 
hydrophilic surfactants at 24 hours and this relationship became accentuated with 
time, C 1 2 E4 -C 1 2 E6  all show significantly greater enhancement ratios than C1 2 E 1 and 
C1 2 E2  after 72 hours (t-test, p> 0.05). These results again pointed to different sites 
or mechanisms of enhancement for OE and HC. Theories of these mechanisms of 
permeation enhancement and correlation to the physical studies with surfactant with 





7.1 Effects of Nonionic Surfactants on Lipid Bilayer Fluidity
The effects of a homologous series of nonionic surfactants upon the fluidity 
of lipid bilayers were studied using three different biophysical techniques, DSC, 
FPS and ESR in order to obtain quantitative structure-activity relationships. The 
three techniques all produced different results in terms of the structure-activity 
relationship observed showing that the choice of method of analysis is important in 
studies such as these. These differences observed in the results, however, provided 
additional information on the mechanisms of action of bilayer fluidisation by the 
surfactants.
Consider the effects of the series of pure dodecyl ether ethoxylates 
Ci2 Eo-Ci2 Eg upon the fluidity of DSPC bilayers at a concentration of 50 mole% 
surfactant. When analysed by DSC it was observed that the most potent fluidiser in 
the series was C 1 2 E3 . Different results were obtained using the other techniques of 
analysis. A large amount of information was obtained from the FPS studies with 
four different probe molecules. The relative efficacy of the surfactants was 
dependent upon the probe molecule structure and its location in the membrane. 
DPH and perylene both sit in the bilayer hydrophobic core. For these two probes 
the most effective fluidisers lay in the range C1 2 E2 -C1 2 E4 . However, when ANS 
was used as the probe the most effective fluidisers were seen to be in the range 
C 1 2 E5 -C1 2 E7 , the surfactants of shorter ethoxy chain length being less effective. 
ANS is known to probe the bilayer headgroup region. Cis-pna can be seen to span 
the whole bilayer as it sits in the same orientation as DSPC molecules. The most 
potent fluidisers amongst the surfactant series for this probe was C1 2 E4 -C1 2 E5 . In 
the ESR studies the most potent effect upon 5-DS was observed with the surfactants 
with long ethoxy chains C1 2 E6 -C1 2 E7 . The possible differences between results 
observed with cis-pna and 5-DS were discussed in Chapter 5.
A possible explanation for these results can be built from the information 
obtained in these investigations. It would appear that the very low HLB surfactants
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C1 2 E0  and C 1 2 E1 have little effect on any part of the membrane. These molecules 
may be impeded by restricted access to the membrane. The short ethoxy chain 
length surfactants C1 2 E2 -C1 2 E4  exert their greatest degree of action on the bilayer 
core fluidising the lipid acyl chains. This was observed with DPH and perylene in 
the FPS study and in the DSC investigation where the changes observed in T^ and 
ATi  ^ relate to the gel-liquid crystalline phase transition which is mainly associated 
with melting of the lipid acyl chains. The longer ethoxy chain length molecules 
exert their effects more at the bilayer surface. This may be on the packing of the 
polar headgroups themselves or on the hydration sphere surrounding the polar 
groups. This was shown by the results with ANS and to some extent 5-DS where 
the reporting group is near to the bilayer surface. The mobility of cis-pna would be 
expected to be effected by events at both the nonpolar core and hydrophillic 
headgroup. The relative potency of the intermediate surfactant C1 2 E5  and the little 
difference observed across the series in reducing the probe anisotropy, r, at 30°C 
may reflect the spanning of the two regions of the bilayer by this probe.
It was suggested in Chapter 3 and in other studies of the effects of series of 
nonionics upon membranes (63,85-87) that the observed structure-activity 
relationships can be explained in terms of the surfactants membrane partition 
coefficient. However if the relative effects were solely due to this all regions would 
be fluidised to the same extent by each surfactant, other factors must therefore 
influence the surfactant action. Florence et al (63) postulated that the depth of alkyl 
chain penetration into the membrane may be affected by the length of the ethoxy 
chain on the hydrophobic group (see 3.4). This theory would seem to be supported 
by this work although further investigation is required.
7.2 Permeation Enhancement by Nonionic Surfactants
As described previously (1.5.4.3) there have been several reports of 
nonionic surfactants increasing percutaneous absorption. In this investigation all the 
surfactants amongst the homologous series C1 2 E0 -C1 2 E8  caused some increase in the 
percutaneous absorption of both a relatively polar compound (hydrocortisone) and a
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nonpolar compound (oestradiol). The structure activity relationships for the 
enhancement of permeation by C 1 2 E0 -C1 2 E8  was different for the two permeants.
The ways in which enhancers may act to increase the absorption of 
compounds through the skin have been discussed earlier in this thesis (1.5.2). The 
enhancer may act to increase the thermodynamic activity or availability of the 
permeant at the skin surface. The enhancer may act as a cosolvent for the drug 
compound in the skin so increasing its partitioning into the stratum comeum, or the 
enhancer may act by decreasing the diffusional resistance of the skin to drug 
diffusion.
Oestradiol is a fairly hydrophobic compound and as such would be expected 
to permeate the stratum comeum mainly through the core of the bilayers of the 
intercellular lipid lamellae. From the physiochemical studies it was shown that the 
best fluidisers of this region of the bilayer were surfactants in the range C1 2 E2 - 
C1 2 E4 . Optimum enhancement of OE permeation was obtained using C1 2 E3  as the 
enhancer. This correlation between the two studies suggests that the surfactants 
acted by fluidising the bilayer core of the lipid lamellae allowing increased diffusion 
of OE through the stratum comeum. A similar mechanism of action has been 
postulated for the enhancers Azone and oleic acid. (54). In a more recent paper 
Ongpipattanakul et al (171) suggested that oleic acid may act by a mechanism 
related to phase separation. Having permeated into the stratum comeum the more 
fluid oleyl chains of the oleic acid may exist as separate domains in the lipids 
providing areas of decreased resistance to permeation. Phase behaviour such as this 
is well documented for phospholipids (172). It is possible that the dodecyl ether 
ethoxylates may act as enhancers by a similar mechanism.
C1 2 E3  was also noted as the optimum enhancer amongst the series of 
surfactants for HC permeation. HC is a relatively polar compound, as discussed in 
Chapter one the major route for the penetration of polar compounds is probably by 
partitioning into and diffusing through the aqueous regions between the lipid bilayer 
headgroups (1.3.1). However, it is unlikely that the aqueous regions would form a
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continuous channel through the stratum comeum. The channels are likely to be 
blocked by lipid membranes as the intercellular lamellae fold around the 
comeocytes. In order to move from one aqueous region to the next, polar 
compounds would have to partition across a lipophilic membrane. This partitioning 
may be the rate limiting step in the diffusion of polar dmgs through the stratum 
comeum. Fluidisation of the membranes would decrease the extent of the barrier 
allowing increased partitioning of polar compounds across the membrane and 
therefore increased permeation. C 1 2 E3  being amongst the optimum fluidisers of 
lipid bilayers will have the highest degree of efficacy upon this process and hence 
be the optimum enhancer for HC as well as OE. These suggestions are comparible 
to those postulated for the action of Azone on polar dmgs (28).
The longer ethoxy chain length surfactants C 1 2 E4 -C1 2 E7  also demonstrated 
high levels of permeation enhancement for HC with respect to those seen for OE. 
The physiochemical studies showed these surfactants affected the upper part of lipid 
bilayers and the polar headgroups. The long ethoxy chains may dismpt the 
hydration sphere around the polar headgroup increasing the amount of "free" water. 
The chains may also help to increase the extent of bilayer hydration (an effect noted 
in the hydration of extracted porcine skin lipid/surfactant mixtures) swelling the 
aqueous phase. Both these effects would increase the aqueous volume available for 
polar dmgs to partition into and so increase their rate of permeation through the 
skin. An increase in aqueous volume would not affect the diffusion of nonpolar 
dmgs, hence the lack of efficacy of the higher HLB surfactants upon OE 
permeation. These suggested possible modes of action of the surfactants as 
permeation enhancers for polar and nonpolar durgs are summarised in Figure 7.1.
The duration of effect of the surfactants upon increased penetration was 
different for the two steroids investigated. For HC there was a marked 'depletion' 
effect noted with surfactants of ethylene oxide chain length of < 4  units. For OE 
permeation this depletion was only noticible for surfactants smaller than C1 2 E2 . In 







was linked to the extent of the depletion and hence tailing of the extent of 
enhancement. The difference observed between OE and HC enhancement would 
suggest that the surfactants ( »  C 1 2 E3 ) need to be present in a higher concentration 
to produce their maximum enhancement for HC than for OE. The increase in 
fluidisation necessary to allow increased partitioning of polar compounds across a 
membrane may be greater than that needed to allow the diffusion of a molecule 
along the membrane. As shown in the DSC, FPS and ESR studies fluidisation was 
proportional to surfactant concentration.
Surfactants are also known to have effects on the keratin of the stratum 
comeum (79,125,173). Little attention has been paid to this possible action of the 
surfactants in this thesis. The involvement of surfactant/protein interaction cannot 
therefore be ruled out. However, little or no change was observed in the keratin 
associated transition in the DSC analysis of C1 2 E3  treated stratum comeum whereas 
the lipid associated peaks were significantly altered. The close relationship 
observed between permeation enhancement and lipid bilayer fluidisation would 
suggest that the skin lipids and not the keratin of the comeocytes are the major site 
of action of the surfactants.
Another effect not fully investigated is the interaction between the surfactant 
and the deposited steroid on the skin surface. The form of the drug on the skin and 
the extent to which it is solubilised by the surfactants may play a role in the 
increased steroid permeation observed.
7.3 The Suitability of Physiochemical Studies as a Screen for Potential 
Penetration Enhancers
Several indirect methods were used in this study to obtain information about 
the penetration enhancing activity of surfactants, i.e. not simple permeation 
experiments. Each method provided different information and entailed different 
degrees of complexity in their procedure. The suitability of each of these methods
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DSC, FPS and ESR to act as quick screens for potential penetration enhancers is 
discussed below.
Two types of analysis were investigated. Those that used model lipid 
membranes made of DSPC and those that used isolated stratum comeum. The 
production and analysis of DSPC/enhancer vesicles for analysis by DSC was the 
simplest and quickest method investigated. This procedure also did not involve the 
purchase of expensive probe molecules. The results obtained from the DSC studies 
were in good agreement with the permeation studies with respect to the 
structure-activity relationship produced, however, the different efficacy of the 
compounds with respect to polar and nonpolar permeants was not observed. The 
methodology of the FPS and ESR studies with liposomes was slightly more complex 
than that used for DSC. The results obtained here were highly probe dependant, 
surface probes giving different results to probes of the membrane core. If polar and 
nonpolar drugs do penetrate the skin via different regions of the extracellular lipid 
lamellae then the choice of probe used could by varied depending upon the drug 
being formulated for transdermal delivery. A fluorescent or nitroxide labelled 
molecule that resembled the drug concemed may be an answer to this, although 
labelling may alter the physiochemical characteristics of the compound.
The preparation of isolated stratum comeum for DSC and ESR studies is 
relatively complex and time comsuming, FPS cannot easily be carried out on intact 
skin samples. DSC of stratum comeum has been shown to provide large amounts 
of information with respect to the effect of enhancers upon the skin (50). However, 
in studies with a range of enhancers the extent of the effects observed by DSC does 
not correlate well to in-vitro permeation results (174). The use of ESR 
spectroscopy upon isolated stratum comeum incorporating a nitroxide probe based 
upon a drug molecule has good potential for use as a screen for enhancers. The 
procedure is more complex than DSC but direct information can be obtained 
conceming the probe (drug) mobility in the skin at physiological temperatures. This 
technique would be usable for all types of drug if spin analogues could be produced.
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however, as stated above the labelling may alter the physiochemical properties of 
the drug molecule and effect its distribution in the skin.
One further point to consider in this discussion is the availability of 
equipment for these screens. Most pharmaceutical research and development 
laboratories either poccesses or have access to DSC, however, few have either a 
fluorescence polarisation spectrometer or an ESR spectrometer.
7.4 Suggestions for Further Work
During the course of this study several questions have arisen conceming the 
effect of surfactants upon DSPC liposomes, skin and enhancement of percutaneous 
absorption. Listed below are some of these points and suggestions for futher 
investigations and continuation of this work.
In the studies using DSPC liposomes as model membrane systems one of the 
suggested reasons for the difference in efficacy of the surfactants was the 
partitioning behavior of the surfactants into the liposomes. This would effect the 
concentration of surfactant present in the membrane. Alkyl ether ethoxylates are 
very difficult to assay quantitatively. However, by the use of radiolabelled 
surfactant molecules it would be possible to easily determine liposome/water 
partition coefficients and assay the actual concentration of the surfactant in the 
membrane. It would also be possible to determine stratum comeum/water partition 
coefficients for the surfactants.
In the discussion to the in-vitro permeation studies it was suggested that the 
shape of the permeation profiles observed with hydrocortisone was due to depletion 
of surfactant from either the skin surface or the active site in the skin. The 
measurement of the permeation rates of the surfactants through the skin would 
determine whether this theory was correct. Again due to the difficulty of analysis 
of these surfactants these experiments would require radiolabelled molecules. By 
using labelled surfactant and ^H labelled drug or vice-versa it would also be 
possible to measure the coflux of these molecules.
211
The interaction of the surfactant with the drug and the physical state of the 
drug upon the skin surface was not determined in this study. Measurement of the 
solubility of the permeants in the surfactant may yield information conceming this 
question.
It was suggested that the surfactants, especially those with longer ethoxy 
chains, may increase the extent of hydration of the stratum comeum and in 
particular the amount of free water present. It may be possible to assess this using 
two thermal analysis techniques, DSC and thermogravimetric analysis (TGA). In 
conjunction with this study it may be possible to observe any swelling of the lipid 
bilayers, due to increased hydration, by small angle X-ray scattering measurements
Further work needs to be undertaken with ESR spectrometery. Determining 
the mobility of labelled model drug compounds in the stratum comeum in-situ may 
yield information conceming mechanisms of action of penetration enhancers and 
routes of drug permeation through the skin. By the use of a variety of different 
probe molecules it may also be possible to determine the site of action of the 
different members of the surfactant series and other enhancers in the skin.
Finally the use of DSPC liposomes has provided useful information 
conceming the effects of surfactants in lipid bilayers. However, the acyl chains of 
the extracellular lipid lamellae in the skin are far longer than the C^g chains of 
DSPC. It may be worth repeating some of the experiments undertaken in this thesis 
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